<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Medical and surgical interventions for the treatment of urinary stones in children - Barreto, L - 2019 | Cochrane Library</title> <meta content="Medical and surgical interventions for the treatment of urinary stones in children - Barreto, L - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010784.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Medical and surgical interventions for the treatment of urinary stones in children - Barreto, L - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010784.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010784.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Medical and surgical interventions for the treatment of urinary stones in children" name="citation_title"/> <meta content="Lenka Barreto" name="citation_author"/> <meta content="King's College Hospital NHS Foundation Trust" name="citation_author_institution"/> <meta content="lenkahumenska@hotmail.co.uk" name="citation_author_email"/> <meta content="Jae Hung Jung" name="citation_author"/> <meta content="Ameera Abdelrahim" name="citation_author"/> <meta content="University Hospitals Birmingham NHS" name="citation_author_institution"/> <meta content="Munir Ahmed" name="citation_author"/> <meta content="King's College Hospital NHS Foundation Trust" name="citation_author_institution"/> <meta content="Guy P C Dawkins" name="citation_author"/> <meta content="King's College Hospital NHS Foundation Trust" name="citation_author_institution"/> <meta content="Marcin Kazmierski" name="citation_author"/> <meta content="Hull Royal Infirmary" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010784.pub3" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/10/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010784.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010784.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010784.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenergic alpha‐Antagonists [*therapeutic use]; Lasers, Solid‐State [therapeutic use]; Length of Stay; Lithotripsy [adverse effects, *methods]; Nephrolithiasis [*therapy]; Randomized Controlled Trials as Topic; Ureterolithiasis [*therapy]; Ureteroscopy [adverse effects, *methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010784.pub3&amp;doi=10.1002/14651858.CD010784.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="XHP2gG4h";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010784\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010784\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","pt","ms","ko","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010784.pub3",title:"Medical and surgical interventions for the treatment of urinary stones in children",firstPublishedDate:"Oct 9, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Urology Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XHP2gG4h&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010784.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010784.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010784.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010784.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010784.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010784.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010784.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010784.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010784.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010784.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3195 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010784.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0164"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-sec-0158"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/appendices#CD010784-sec-0169"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/table_n/CD010784StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/table_n/CD010784StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Medical and surgical interventions for the treatment of urinary stones in children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#CD010784-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Lenka Barreto</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#CD010784-cr-0003">Jae Hung Jung</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#CD010784-cr-0004">Ameera Abdelrahim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#CD010784-cr-0005">Munir Ahmed</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#CD010784-cr-0006">Guy P C Dawkins</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information#CD010784-cr-0007">Marcin Kazmierski</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information/en#CD010784-sec-0175">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 October 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010784.pub3">https://doi.org/10.1002/14651858.CD010784.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010784-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010784-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010784-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010784-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010784-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010784-abs-0011">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010784-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010784-abs-0001" lang="en"> <section id="CD010784-sec-0001"> <h3 class="title" id="CD010784-sec-0001">Background</h3> <p>Urolithiasis is a condition where crystalline mineral deposits (stones) form within the urinary tract. Urinary stones can be located in any part of the urinary tract. Affected children may present with abdominal pain, blood in the urine or signs of infection. Radiological evaluation is used to confirm the diagnosis, to assess the size of the stone, its location, and the degree of possible urinary obstruction. </p> </section> <section id="CD010784-sec-0002"> <h3 class="title" id="CD010784-sec-0002">Objectives</h3> <p>To assess the effects of different medical and surgical interventions in the treatment of urinary tract stones of the kidney or ureter in children. </p> </section> <section id="CD010784-sec-0003"> <h3 class="title" id="CD010784-sec-0003">Search methods</h3> <p>We searched the Cochrane Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), Embase (Ovid) as well as the World Health Organization International Clinical Trials Registry Platform Search Portal and ClinicalTrials.gov. We searched reference lists of retrieved articles and conducted an electronic search for conference abstracts for the years 2012 to 2017. The date of the last search of all electronic databases was 31 December 2017 and we applied no language restrictions. </p> </section> <section id="CD010784-sec-0004"> <h3 class="title" id="CD010784-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials (RCTs) and quasi‐RCTs looking at interventions for upper urinary tract stones in children. These included shock wave lithotripsy, percutaneous nephrolithotripsy, ureterorenoscopy, open surgery and medical expulsion therapy for upper urinary tract stones in children aged 0 to 18 years. </p> </section> <section id="CD010784-sec-0005"> <h3 class="title" id="CD010784-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures according to Cochrane guidance. Two review authors independently searched and assessed studies for eligibility and conducted data extraction. 'Risk of bias' assessments were completed by three review authors independently. We used Review Manager 5 for data synthesis and analysis. We used the GRADE approach to assess the quality of evidence. </p> </section> <section id="CD010784-sec-0006"> <h3 class="title" id="CD010784-sec-0006">Main results</h3> <p>We included 14 studies with a total of 978 randomised participants in our review, informing eight comparisons. The studies contributing to most comparisons were at high or unclear risk of bias for most domains. </p> <p><b>Shock wave lithotripsy versus dissolution therapy for intrarenal stones:</b> based on one study (87 participants) and consistently very low quality evidence, we are uncertain about the effects of SWL on stone‐free rate (SFR), serious adverse events or complications of treatment and secondary procedures for residual fragments. </p> <p><b>Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones:</b> based on one study (60 participants) and consistently very low quality evidence, we are uncertain about the effects of SWL on SFR, serious adverse events or complications of treatment and secondary procedures for residual fragments. </p> <p><b>Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones:</b> based on three studies (153 participants) and consistently very low quality evidence, we are uncertain about the effects of SWL on SFR, serious adverse events or complications of treatment and secondary procedures. </p> <p><b>Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones:</b> based on one study (212 participants), SWL likely has a lower SFR (RR 0.88, 95% CI 0.80 to 0.97; moderate quality evidence); this corresponds to 113 fewer stone‐free patients per 1000 (189 fewer to 28 fewer). SWL may reduce severe adverse events (RR 0.13, 95% CI 0.02 to 0.98; low quality evidence); this corresponds to 66 fewer serious adverse events or complications per 1000 (74 fewer to 2 fewer). Rates of secondary procedures may be higher (RR 2.50, 95% CI 1.01 to 6.20; low‐quality evidence); this corresponds to 85 more secondary procedures per 1000 (1 more to 294 more). </p> <p><b>Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones:</b> based on one study (23 participants) and consistently very low quality evidence, we are uncertain about the effects of percutaneous nephrolithotripsy on SFR, serious adverse events or complications of treatment and secondary procedures. </p> <p><b>Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones:</b> based on one study (70 participants), SFR are likely similar (RR 1.03, 95% CI 0.93 to 1.14; moderate‐quality evidence); this corresponds to 28 more per 1,000 (66 fewer to 132 more). We did not find any data relating to serious adverse events. Based on very low quality evidence we are uncertain about secondary procedures. </p> <p><b>Alpha‐blockers versus placebo with or without analgesics for distal ureteric stones:</b> based on six studies (335 participants), alpha‐blockers may increase SFR (RR 1.34, 95% CI 1.16 to 1.54; low quality evidence); this corresponds to 199 more stone‐free patients per 1000 (94 more to 317 more). Based on very low quality evidence we are uncertain about serious adverse events or complications and secondary procedures. </p> </section> <section id="CD010784-sec-0007"> <h3 class="title" id="CD010784-sec-0007">Authors' conclusions</h3> <p>Based on mostly very low‐quality evidence for most comparisons and outcomes, we are uncertain about the effect of nearly all medical and surgical interventions to treat stone disease in children.Common reasons why we downgraded our assessments of the quality of evidence were: study limitations (risk of bias), indirectness, and imprecision. These issues make it difficult to draw clinical inferences. It is important that affected individuals, clinicians, and policy‐makers are aware of these limitations of the evidence. There is a critical need for better quality trials assessing patient‐important outcomes in children with stone disease to inform future guidelines on the management of this condition. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010784-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010784-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010784-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010784-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010784-abs-0013">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010784-abs-0012">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010784-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010784-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010784-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010784-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010784-abs-0005" lang="en"> <h3>Interventions for treating urinary stones in children</h3> <p><b>Review question</b> </p> <p>What is the evidence for treating stones of the kidney or ureter in children?</p> <p><b>Background</b> </p> <p>Urinary stones occur in up to 5 in 100 children in high‐income countries. These rates have been noted to be increasing. To treat urinary stones in children, urologists use medications, shock wave therapy, open surgery, and small scopes that are put into the bladder or through the skin. It is not clear how well each of these treatments work and what the side effects are. </p> <p><b>Study characteristics</b> </p> <p>We included 14 studies with a total of 978 randomised children with stones in either the kidney or ureter, which connects the kidney to the bladder. The number of children in the studies varied from 22 to 221 children. There were seven trials of different types of surgery, four trials of medications and one study that compared medication with surgery. The amount of time the trials followed participants for ranged from one week to one year. </p> <p><b>Key results</b> </p> <p>Shock waves versus medication to dissolve stones: we are uncertain about the effect on successful removal of stones, serious complications and the need for a second procedure to treat the stones. </p> <p>Shock waves given slowly versus shock waves given fast: we are uncertain about the effect of slow shock waves on successful removal of stones. We are also uncertain about the effect on serious complications and the need for other procedures. </p> <p>Shock waves versus treatment using a scope through the bladder to break up the stone: we are uncertain about the effect of shock waves on successful removal of stones compared to using a scope. We are also uncertain about the effect on serious complications and the need for other procedures. </p> <p>Shock waves versus treatment using a scope through the skin into the kidney: shock waves are likely less successful in the removal of stones. Shock waves appears to reduce severe adverse events but more often secondary procedures are needed to remove all the stones. </p> <p>Use of a scope through the kidney with a drainage tube afterwards versus without a drainage tube: we are uncertain about the effect on successful removal of stones, serious complications or the need for more procedures. </p> <p>Use of a scope through the kidney with a regular versus very small ("mini") tube through the skin: successful removal of stones are likely similar in both procedures. We did not find any data relating to serious adverse events. We are uncertain about the effect on the need for another procedure. </p> <p>Alpha‐blockers versus placebo with or without ibuprofen: alpha‐blockers may increase successful removal of stones. We are uncertain about serious complications and the need for more procedures. </p> <p><b>Quality of the evidence.</b> </p> <p>The quality of evidence for most outcomes was very low. This means that we are very uncertain about most of the review findings. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010784-sec-0164" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010784-sec-0164"></div> <h3 class="title" id="CD010784-sec-0165">Implications for practice</h3> <section id="CD010784-sec-0165"> <p>Based on the findings of this review, there is considerable uncertainty with regards to the effectiveness and adverse events associated with the various types of interventions used to treat paediatric upper renal tract stone disease. It is important for patients, clinicians, guideline developers and policy‐makers to be aware of these limitations. Well‐informed, shared decision‐making is important to achieve the right balance of SFRs and treatment related morbidity to match individual patients' personal circumstances, values and preferences. An important consideration is the surgeon's training and skills as well as the availability of various technologies in different geographical locations and healthcare systems. </p> </section> <h3 class="title" id="CD010784-sec-0166">Implications for research</h3> <section id="CD010784-sec-0166"> <p>Given the predominantly low‐ and very‐low quality of the evidence we encountered to inform interventions for treating urinary stones in children, there is a critical need for higher quality trials which include adequate sample sizes, report findings transparently, and avoid study limitations. Additional things to consider are the explicit reporting of participants' baseline characteristics and the standardised reporting of patient‐important outcomes. Prior studies have described the paucity of RCTs in paediatric urology and their poor quality of reporting (<a href="./references#CD010784-bbs2-0062" title="WelkB , AfsharK , MacNeilyAE . Randomized controlled trials in pediatric urology: room for improvement. Journal of Urology2006;176(1):306‐9; discussion 309‐10. ">Welk 2006</a>). These issues mirror the reporting of stone disease‐related trials in the adult population (<a href="./references#CD010784-bbs2-0066" title="ZavitsanosPJ , BirdVG , MinceKA , NeubergerMM , DahmP . Low methodological and reporting quality of randomized, controlled trials of devices to treat urolithiasis. Journal of Urology2014;191(4):988‐93. ">Zavitsanos 2014</a>). </p> <p>The challenges of trials related to surgical innovation have been well described (<a href="./references#CD010784-bbs2-0041" title="McCullochP , AltmanDG , CampbellWB , FlumDR , GlasziouP , MarshallJC , et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet2009;374(9695):1105‐12. ">McCulloch 2009</a>; <a href="./references#CD010784-bbs2-0042" title="McCullochP . The IDEAL recommendations and urological innovation. World Journal of Urology2011;29(3):331‐6. ">McCulloch 2011</a>). These include a reluctance to accept random allocation, challenges in blinding, and issues related to continued evolution of the intervention of interest and the surgical learning curves. Nevertheless, they are critically important to inform clinical decision‐making. The IDEAL Collaboration has provided recommendations for surgical innovation (<a href="./references#CD010784-bbs2-0042" title="McCullochP . The IDEAL recommendations and urological innovation. World Journal of Urology2011;29(3):331‐6. ">McCulloch 2011</a>) that have found recent adaptation to surgical devices (<a href="./references#CD010784-bbs2-0055" title="SedrakyanA , CampbellB , MerinoJG , KuntzR , HirstA , McCullochP . IDEAL‐D: a rational framework for evaluating and regulating the use of medical devices. BMJ2016;353:i2372. ">Sedrakyan 2016</a>). </p> <p>Short of surgical trials which are highly desirable, prospectively designed cohort studies that use statistical methods to adjust for baseline confounding and use standardised methods for outcome collection and assessment may also provide higher quality evidence in cases in which the QoE is only low or very low (<a href="./references#CD010784-bbs2-0053" title="SchunemannHJ , TugwellP , ReevesBC , AklEA , SantessoN , SpencerFA , et al. Non‐randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions. Research Synthesis Methods2013;4(1):49‐62. ">Schunemann 2013</a>). Although a search for such studies was outside of the scope of this review, we doubt whether they currently exist. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010784-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010784-sec-0029"></div> <div class="table" id="CD010784-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Shock wave lithotripsy versus dissolution therapy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with uncomplicated radiolucent renal stone </p> <p><b>Intervention:</b> SWL (Lithotripter S; total count of 2,000 per session at 12 to 14 kV power and a frequency of 60 to 70 per minute) under general anaesthesia </p> <p><b>Control:</b> oral potassium sodium hydrogen citrate at a dose of 1 mEq/kg per day in 2 or 3 divided doses after meals </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Dissolution therapy for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>87<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/> (0.90 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>729 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 more per 1,000<br/> (73 fewer to 299 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>87<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.23<br/> (0.08 to 19.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 more per 1,000<br/> (19 fewer to 376 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures for residual fragments<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>87<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.29 to 1.50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>271 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92 fewer per 1,000<br/> (192 fewer to 135 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear or high risk of bias in almost all domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010784-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with solitary radiopaque renal stone </p> <p><b>Intervention:</b> SWL (Dornier Lithotripter S; total count of 2,500 per session at 14 to 24 kV power) at 80 shock waves per minute </p> <p><b>Control:</b> SWL (Dornier Lithotripter S; total count of 2,500 per session at 14 to 24 kV power) at 120 shock waves per minute </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with rapid SWL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with slow SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 1 month </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.25<br/> (1.16 to 4.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>267 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333 more per 1,000<br/> (43 more to 896 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 1 month </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures</p> <p>Follow‐up: not reported (minimum 1 month)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.38<br/> (0.11 to 1.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>267 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165 fewer per 1,000<br/> (237 fewer to 75 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear risk of bias in half or more domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinical meaningful threshold. </p> <p><sup>3</sup> Downgraded by two levels for imprecision: very rare event in either group. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010784-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with renal or distal ureteric stones </p> <p><b>Intervention:</b> SWL (Compact Delta II with 1,250 to 2,400 (mean 1,530) shockwave and power ranged from 11 to 13 kV, EDAP‐Sonolith 4000 with 2500 shock waves (1900–3500) and 450 KJ (330–694)) </p> <p><b>Control:</b> lithotripsy with holmium laser and/or pneumatic lithotriptor </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Ureteroscopy with Holmium laser or Pneumatic lithotripsy for distal ureteric stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: range 2 weeks to 8 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>153<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.62<br/> (0.43 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>859 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>326 fewer per 1,000<br/> (490 fewer to 103 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: range 2 weeks to 8 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>153<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.56<br/> (0.12 to 2.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 fewer per 1,000<br/> (45 fewer to 81 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Second procedures<br/> Follow‐up: range 2 weeks to 8 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>131<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.47<br/> (1.32 to 9.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>149 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>369 more per 1,000<br/> (48 more to 1,216 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: hours </p> <p>Follow‐up: range 2 weeks to 3 months<sup>5</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>122<br/> (2 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay ranged from 4 to 36 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 10.71 hours lower<br/> (34.09 lower to 12.67 higher) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear of high risk of bias in half or more domains among the included studies. </p> <p><sup>2</sup> Downgraded by one level for indirectness: discrepancies in inclusion criterion (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a> included only participants with a solitary kidney) and baseline stone size among included studies. In addition, stones were in different locations (renal and distal ureter) among included studies. </p> <p><sup>3</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> <p><sup>4</sup> Downgraded by one level for imprecision: confidence interval crosses clinically meaningful threshold. </p> <p><sup>5</sup><a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a> did not report the follow‐up period. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010784-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> age &lt; 15 years and single radio‐opaque lower calyceal calculus 1‐2cm </p> <p><b>Intervention:</b> SWL as an outpatient procedure (Dornier Alpha Compact system; maximum 2,500 per session and a frequency of 90 per minute) </p> <p><b>Control:</b> mini‐PCNL under general anaesthesia </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Mini‐PCNL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.88<br/> (0.80 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>943 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113 fewer per 1,000<br/> (189 fewer to 28 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.13</p> <p>(0.02 to 0.98)</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66 fewer per 1,000</p> <p>(74 fewer to 2 fewer)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.50<br/> (1.01 to 6.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 more per 1,000<br/> (1 more to 294 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: days<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay was 3.7 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.4 days lower<br/> (5.43 lower to 1.37 lower) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>PCNL:</b> percutaneous nephrolithotomy; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear of high risk of bias in half or more domains. </p> <p><sup>2</sup> Downgraded by one level for imprecision: confidence interval crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010784-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> age &lt; 14 years, presence of renal stone larger than 2.5 cm or renal stone with lesser diameter, and extracorporeal shockwave lithotripsy failure </p> <p><b>Intervention:</b> PCNL under general anaesthesia </p> <p><b>Control:</b> tubeless PCNL under general anaesthesia </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Tubeless PCNL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with PCNL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.16<br/> (0.88 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>846 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135 more per 1,000<br/> (102 fewer to 448 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatments<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.42<br/> (0.02 to 9.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 fewer per 1,000</p> <p>(75 fewer to 648 more)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.42<br/> (0.02 to 9.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 fewer per 1,000<br/> (75 fewer to 648 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: hours<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay was 39.5 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 19.2 hours more<br/> (10.2 more to 28.08 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>PCNL:</b> percutaneous nephrolithotomy; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear or high risk of bias in half or more domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> <p><sup>3</sup> Downgraded by one level for imprecision: confidence interval crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010784-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> preschool children under 3 years with renal calculi </p> <p><b>Intervention:</b> PCNL under general anaesthesia </p> <p><b>Control:</b> mini‐PCNL under general anaesthesia </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Mini‐PCNL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with PCNL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.93 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>943 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 more per 1,000<br/> (66 fewer to 132 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events or complications of treatment — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures<br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: days<br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay was 4.6 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.14 days more<br/> (2.78 more to 3.5 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>PCNL:</b> percutaneous nephrolithotomy; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear risk of bias in almost all domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: very rare event in either group. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010784-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Alpha‐blockers versus placebo with/without analgesics</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with radiopaque lower ureteral stones </p> <p><b>Intervention:</b> alpha blockers (doxazosin, tamsulosin, or silodosin) </p> <p><b>Control:</b> placebo with/without analgesics </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo with/without analgesics</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with alpha‐blockers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: range 3 weeks to 4 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>335<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.34<br/> (1.16 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>587 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199 more per 1,000<br/> (94 more to 317 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 4 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>63<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures for residual fragments<br/> Follow‐up: mean 3 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/> (0.15 to 1.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141 fewer per 1,000<br/> (255 fewer to 243 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear or high risk of bias in one or more domains. </p> <p><sup>2</sup> Downgraded by one levels for imprecision: confidence interval is crosses clinically meaningful threshold. </p> <p><sup>3</sup> Downgraded by two levels for imprecision: very rare event in either group. </p> <p><sup>4</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010784-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010784-sec-0030"></div> <section id="CD010784-sec-0031"> <h3 class="title" id="CD010784-sec-0031">Description of the condition</h3> <p>Urolithiasis or stone disease is a condition where crystalline mineral deposits form within the urinary tract. Metabolic, anatomical factors, iatrogenic and idiopathic causes all contribute to stone formation. In children, urinary tract infections can contribute to stone development. </p> <p>Formation of the urinary stones is positively enhanced by increased concentrations of uric acid, calcium, oxalate and cystine molecules. Crystallisation inhibitors such as citrate, magnesium, glycosaminoglycans and pyrophosphate play an important role as inhibitors in the formation of the urinary stones and their depletion may be the main cause of the stone formation. </p> <p>Composition of the stones, their location in the urinary tract and prevalence of the disease varies around the world. The prevalence rate in low‐ to middle‐income countries such as Pakistan and Turkey is 5% to 15% (<a href="./references#CD010784-bbs2-0057" title="ShahAM , KalmunkarS , PunekarSV , BillimoriaFR , BapatSD , DeshmukhSS . Spectrum of pediatric urolithiasis in Western India. Indian Journal of Pediatrics1991;58(4):543‐9. [MEDLINE: 1800338] ">Shah 1991</a>), compared with 1% to 5% in high‐income countries (<a href="./references#CD010784-bbs2-0028" title="ElsobkyE , SheirKZ , MadboulyK , MokhtarAA . Extracorporeal shock wave lithotripsy in children: experience using two second‐generation lithotripters. BJU International2000;86(7):851‐6. [MEDLINE: 11069413] ">Elsobky 2000</a>; <a href="./references#CD010784-bbs2-0065" title="YoshidaO , OkadaY . Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urologia Internationalis1990;45(2):104‐11. [MEDLINE: 2330656] ">Yoshida 1990</a>). Overall girls are more susceptible to nephrolithiasis than boys (<a href="./references#CD010784-bbs2-0043" title="NovakTE , LakshmananY , TrockBJ , GearhartJP , MatlagaBR . Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology2009;74(1):104‐7. ">Novak 2009</a>). </p> <p>Urinary stones can be located in any part of the urinary tract. Many stones found in children born in low‐ to middle‐income countries are located within the urinary bladder (<a href="./references#CD010784-bbs2-0049" title="RizviSA , NaqviSA , HussainZ , HashmiA , HussainM , ZafarMN , et al. Pediatric urolithiasis: developing nation perspectives. Journal of Urology2002;168(4 Pt 1):1522‐5. [MEDLINE: 12352448] ">Rizvi 2002</a>; <a href="./references#CD010784-bbs2-0050" title="RizviSA , NaqviSA , HussainZ , HashmiA , HussainM , ZafarMN , et al. Management of pediatric urolithiasis in Pakistan: experience with 1,440 children. Journal of Urology2003;169(2):134‐7. [MEDLINE: 12544331] ">Rizvi 2003</a>). There is some evidence to suggest that the predominant location of urinary stones has shifted from the bladder to the upper urinary tract over a 13‐year period from 1987 to 2000 (<a href="./references#CD010784-bbs2-0049" title="RizviSA , NaqviSA , HussainZ , HashmiA , HussainM , ZafarMN , et al. Pediatric urolithiasis: developing nation perspectives. Journal of Urology2002;168(4 Pt 1):1522‐5. [MEDLINE: 12352448] ">Rizvi 2002</a>). Of these cases, 75% to 80% have upper urinary tract stones and 5% are caused by infection (<a href="./references#CD010784-bbs2-0044" title="OzokutanBH , KucukaydinM , GunduzZ , KabakliogluM , OkurH , TuranC . Urolithiasis in childhood. Paediatric Surgery International2000;1‐2(1‐2):60‐3. [MEDLINE: 10663838] ">Ozokutan 2000</a>). </p> <p>The manifestation and clinical presentation of urinary stones in children differs from the adult population and can vary with age. Fifty per cent of children will present with abdominal pain, 33% with haematuria and 11% with infection. Children under the age of five years most commonly present with blood in the urine, while pain is a more common finding in older children. In younger children the localisation of pain is not as typical as in adults and flank pain radiating to the groin is rare (<a href="./references#CD010784-bbs2-0051" title="Santos‐VictorianoM , BrouhardBH , CunninghamRJ3rd . Renal stone disease in children. Clinical Pediatrics1998;37(10):583‐99. [MEDLINE: 9793728] ">Santos‐Victoriano 1998</a>). Pain in children with stones can have a distribution such as appendicitis or gastroenteritis. In infants, the only presenting sign of stone disease might be urinary tract infection. </p> <p>Diagnosis is confirmed by radiological evaluation which is also used to assess the size of the stone, location and the degree of possible urinary obstruction. </p> </section> <section id="CD010784-sec-0032"> <h3 class="title" id="CD010784-sec-0032">Description of the intervention</h3> <p>The most appropriate management strategy depends on a number of factors, principally the size, location and composition of the stone. Other factors influencing management include the availability of different treatment options, local expertise, as well as anatomical variations such as in children with congenital abnormalities of the urinary tract.  </p> <p>Shock wave lithotripsy (SWL) involves the use of shock waves focused from outside the body onto the stone. It is a commonly used therapy for children with smaller upper urinary tract stones as long as there is adequate drainage of the urinary system below the level of the stone. SWL can also be used for treatment of ureteric stones. Success rates and complications are significantly affected by the location of the stone and can also depend on the type of machine used. </p> <p>In children with larger and more complex stone disease percutaneous nephrolithotripsy (PCNL) is widely used, which involves establishing a percutaneous working tract to fragment and remove the stone(s) using ultrasound, laser or pneumatic lithotripsy. This technique is considered in children with large upper tract stones (1.5 cm or larger). Until recently this technique was limited by the availability of appropriately sized instruments however paediatric‐size instruments are now available (<a href="./references#CD010784-bbs2-0025" title="DesaiM . Endoscopic management of stones in children. Current Opinion in Urology2005;15(2):107‐12. [MEDLINE: 15725934] ">Desai 2005</a>). </p> <p>Children with stones within the ureter or collecting system may be treated by ureterorenoscopy, which involves insertion of a ureterorenoscope through the bladder. One limitation is that in smaller children the size of the ureteric orifice may be insufficient to accommodate an ureterorenoscope. Different contact lithotripsy techniques — such as laser, ultrasound, and pneumatic lithotripsy — can be utilised with ureterorenoscopy. This technique is mainly used in children with a stone size from 4 mm where visualisation during SWL has failed or cannot be done. </p> <p>Open stone surgery may be used in very young children with large stones or in children with a large stone which would require multiple endoscopic procedures. It is also indicated in children with a stone in the presence of congenital anomalies of the urinary system or orthopaedic anomalies where operative positioning is impossible. Open surgery is rarely indicated as first‐line treatment in children. It has the advantage of very high primary stone clearance rates but this radical approach has obvious disadvantages and potential complications. Laparascopic and robotic surgery are becoming more popular in the treatment of various urological conditions requiring a surgical approach, but is not yet commonly used in the treatment of paediatric stones (<a href="./references#CD010784-bbs2-0023" title="DahmP , SedrakyanA , McCullochP . Application of the IDEAL Framework to Robotic Urologic Surgery. European Urology2014;65(5):849‐51. ">Dahm 2014</a>). </p> <p>Medical expulsion therapy is a conservative medication‐based method of stone management. It involves the administration of medications to accelerate and facilitate the spontaneous passage of ureteric stones. Corticosteroids, hormones, nonsteroidal anti‐inflammatory agents, calcium‐channel blockers and alpha‐adrenergic blockers have been used in the conservative management of stone disease. </p> <p>The stone‐free rate (SFR) is the measure of success of the intervention. However, there is currently no consensus regarding the size of the fragment to define 'stone‐free' for children. Fragments of 3 mm or less are often regarded as insignificant in adult practice. A child's capacity to pass a stone has been shown to be greater than in adults, probably due to higher tissue compliance. Kidney stones less than 3 mm are likely to pass spontaneously and the chance of passing a ureteric stone less than 5 mm is approximately 70%. The passage rate of stones greater than 5 mm does not depend on age in children older than one year (<a href="./references#CD010784-bbs2-0047" title="PietrowPK , PopeJC4th , AdamsMC , ShyrJ , BrockJW3rd . Clinical outcome of pediatric stone disease. Journal of Urology2002;167(2 Pt 1):670‐3. [MEDLINE: 11792950] ">Pietrow 2002</a>). </p> </section> <section id="CD010784-sec-0033"> <h3 class="title" id="CD010784-sec-0033">How the intervention might work</h3> <p>SWL is thought to be relatively safe and effective. The reported SFR following treatment depends on the location and size of the stone. There is a negative correlation between stone size and effectiveness of stone clearance. The disadvantages of SWL include the need for potential fluoroscopic localisation of some stones and the inability to adequately focus the energy in smaller children, as the machines in use are designed for older patients. The equipment is bulky and cumbersome and difficult to move; in children the technique is typically performed under general anaesthesia, and many patients with kidney stones have significant co‐morbidities making this an important consideration when multiple attempts at stone clearance may be required. Complications of SWL can include urosepsis, haematuria, flank pain, and ‘steinstrasse’. There is risk of hypertension in SWL application to the kidney (<a href="./references#CD010784-bbs2-0024" title="DenburgMR , JemielitaTO , TasianGE , HaynesK , MucksavageP , ShultsJ , et al. Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy. Kidney International2016;89(1):185‐92. ">Denburg 2016</a>). All of these complications are less common with second generation lithotriptors (<a href="./references#CD010784-bbs2-0039" title="KroovandRH , HarrisonLH , McCulloughDL . Extracorporeal shock wave lithotripsy in childhood. Journal of Urology1987;138(4 Pt 2):1106‐8. [MEDLINE: 3656568] ">Kroovand 1987</a>). The stone‐free range for SWL reported by most centres for moderate sized stones is between 70% and 80% (<a href="./references#CD010784-bbs2-0046" title="PicramenosD , DeliveliotisC , AlexopoulouK , MakrichoritisC , KostakopoulosA , DimopoulosC . Extracorporeal shock wave lithotripsy for renal stones in children. Urology International1996;56(2):86‐9. [MEDLINE: 8659016] ">Picramenos 1996</a>; <a href="./references#CD010784-bbs2-0060" title="VanHornAC , HollanderJB , KassEJ . First and second generation lithotripsy in children: results, comparison and followup. Journal of Urology1995;153(6):1969‐71. [MEDLINE: 7752373] ">Van Horn 1995</a>). SWL is the least invasive procedure for the management of most types of stones in children. </p> <p>PCNL in children was first reported 30 years ago by Woodside and colleagues (<a href="./references#CD010784-bbs2-0064" title="WoodsideJR , StevensGF , StarkGL , BordenTA , BallWS . Percutaneous stone removal in children. Journal of Urology1985;134(6):1166‐7. [MEDLINE: 4057408] ">Woodside 1985</a>). Initial results were excellent with a reported SFR of 100% and no complications. Subsequent publications have demonstrated a number of potential complications of PCNL including renal scarring (<a href="./references#CD010784-bbs2-0063" title="WilsonWT , HusmannDA , MorrisJS , MillerGL , AlexanderM , PremingerGM . A comparison of the bioeffects of four different modes of stone therapy on renal function and morphology. Journal of Urology1993;150(4):1267‐70. [MEDLINE: 8371413] ">Wilson 1993</a>), bleeding, postoperative infection and persistent urinary leakage. Standard PCNL involves usage of percutaneous tubes to maintain adequate drainage of the kidney post procedure. Due to the belief that the nephrostomy tubes can contribute to postoperative pain, use of small nephrostomy tubes or a 'tubeless' approach via ureteric stents or catheters instead of nephrostomy tubes has been developed. </p> <p>Use of ureteroscopic techniques is similar to those in adults. Complete stone clearance rates of up to 90% have been reported with the use of a semi‐rigid ureteroscope (<a href="./references#CD010784-bbs2-0027" title="DoganHS , OnalB , SatarN , AygunC , PiskinM , TanriverdiO , et al. Factors affecting complication rates of ureteroscopic lithotripsy in children: results of multi‐institutional retrospective analysis by Pediatric Stone Disease Study Group of Turkish Pediatric Urology Society. Journal of Urology2011;186(3):1035‐40. [MEDLINE: 21784482] ">Dogan 2011</a>). The incidence of vesicoureteric reflux disease after ureteroscopy is very low (<a href="./references#CD010784-bbs2-0058" title="ThomasR , OrtenbergJ , LeeBR , HarmonEP . Safety and efficacy of pediatric ureteroscopy for management of calculous disease. Journal of Urology1993;149(5):1082‐4. [MEDLINE: 8483216] ">Thomas 1993</a>). </p> <p>Alpha‐1 adrenergic receptors are located throughout the human ureter. The physiologic response to antagonism of these receptors is decreased contraction, decreased peristaltic frequency, and increased fluid bolus volume transported down the ureter. Alpha‐blockers (specifically alpha‐1 antagonists) increase the spontaneous expulsion rate of distal ureteric stones, hence reducing the time to stone passage. The rate of spontaneous passage with no medical intervention for a stone of less than 5 mm located in the proximal ureter is 29% to 98% and in the distal ureter is 71% to 98% (<a href="./references#CD010784-bbs2-0056" title="SeguraJW , PremingerGM , AssimosDG , DretlerSP , KahnRI , LingemanJE , et al. Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. The American Urological Association. Journal of Urology1997;158(5):1915‐21. [MEDLINE: 9334635] ">Segura 1997</a>). </p> </section> <section id="CD010784-sec-0034"> <h3 class="title" id="CD010784-sec-0034">Why it is important to do this review</h3> <p>There is a large body of evidence on the management of upper urinary tract stone disease in adults, but significantly less evidence on the management in children. Although urinary stones are less prevalent in children than in adults, they are associated with significant morbidity and there is evidence that the incidence is increasing (<a href="./references#CD010784-bbs2-0022" title="ClaytonDB , PopeJC . The increasing pediatric stone disease problem. Therapeutic Advances in Urology2011;3(1):3‐12. ">Clayton 2011</a>). In addition, recent technological developments in stone management has expanded the treatment choices. </p> <p>While there are existing systematic reviews that assess the effects of medical expulsive therapy and ureteroscopy (<a href="./references#CD010784-bbs2-0029" title="GlinaFP , CastroPM , MonteiroGG , DelGuerraGC , GlinaS , MazzuranaM , et al. The use of alpha‐1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta‐analysis. International Brazilian Journal of Urology2015;41(6):1049‐57. ">Glina 2015</a>; <a href="./references#CD010784-bbs2-0036" title="IshiiH , GriffinS , SomaniBK . Flexible ureteroscopy and lasertripsy (FURSL) for paediatric renal calculi: results from a systematic review. Journal of Pediatric Urology2014;10(6):1020‐5. ">Ishii 2014</a>; <a href="./references#CD010784-bbs2-0037" title="IshiiH , GriffinS , SomaniBK . Ureteroscopy for stone disease in the paediatric population: a systematic review. BJU International2015;115(6):867‐73. ">Ishii 2015</a>; <a href="./references#CD010784-bbs2-0059" title="TianD , LiN , HuangW , ZongH , ZhangY . The efficacy and safety of adrenergic alpha‐antagonists in treatment of distal ureteral stones in pediatric patients: A systematic review and meta‐analysis. Journal of Pediatric Surgery2017;52(2):360‐5. ">Tian 2017</a>; <a href="./references#CD010784-bbs2-0061" title="VelazquezN , ZapataD , WangHH , WienerJS , LipkinME , RouthJC . Medical expulsive therapy for pediatric urolithiasis: Systematic review and meta‐analysis. Journal of Pediatric Urology2015;11(6):321‐7. ">Velazquez 2015</a>) the reviews are less rigorous and include non‐randomised controlled trials regardless of study design. Furthermore, none apply the GRADE approach or use the same methodology as Cochrane reviews (<a href="./references#CD010784-bbs2-0031" title='GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , SchünemannHJ , et al. GRADE: what is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.)2008;336(7651):955‐8. [DOI: 10.1136/bmj.39490.551019.BE] '>Guyatt 2008</a>). </p> <p>In this era, with the availability of numerous procedures for the treatment of urinary tract stones in children, the findings of this Cochrane Review will be relevant to policymakers, healthcare providers and patients. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010784-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010784-sec-0035"></div> <p>To assess the effects of different medical and surgical interventions in the treatment of urinary tract stones of the kidney or ureter in children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010784-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010784-sec-0036"></div> <section id="CD010784-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010784-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods). </p> </section> <section id="CD010784-sec-0039"> <h4 class="title">Types of participants</h4> <section id="CD010784-sec-0040"> <h5 class="title">Inclusion criteria</h5> <p>We included children (aged 0 to 18 years) with upper tract urinary stones confirmed by imaging, who required medical or surgical intervention. </p> </section> <section id="CD010784-sec-0041"> <h5 class="title">Exclusion criteria</h5> <p>We excluded trials of children with lower urinary tract stones such as urinary bladder or urethral stones, active urinary tract infection, urinary tract anomalies, non‐functioning kidney, previously diagnosed reflux, voiding dysfunction, and history of ureteral or bladder surgery (or both). </p> </section> <section id="CD010784-sec-0042"> <h5 class="title">Diagnostic criteria for urinary stone</h5> <p>Stone diagnosis was made by sonography or kidney‐ureter‐bladder radiography and was confirmed by intravenous urography or computerised tomography (CT) scan. </p> </section> </section> <section id="CD010784-sec-0043"> <h4 class="title">Types of interventions</h4> <p>The following interventions have been examined and compared.</p> <p> <ul id="CD010784-list-0001"> <li> <p>Shock wave lithotripsy.</p> </li> <li> <p>Percutaneous nephrolithotripsy.</p> </li> <li> <p>Ureterorenoscopy (regardless of the type of lithotripsy).</p> </li> <li> <p>Open stone surgery.</p> </li> <li> <p>Medical expulsive therapy.</p> </li> </ul> </p> <p>Studies comparing surgical and medical management have been included.</p> </section> <section id="CD010784-sec-0044"> <h4 class="title">Types of outcome measures</h4> <section id="CD010784-sec-0045"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010784-list-0002"> <li> <p>Stone‐free rate.</p> </li> <li> <p>Serious adverse events or complications of treatment.</p> </li> <li> <p>Secondary procedures for residual fragments.</p> </li> </ul> </p> </section> <section id="CD010784-sec-0046"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010784-list-0003"> <li> <p>Hospital stay.</p> </li> <li> <p>Pain.</p> </li> </ul> </p> <p>Our primary and secondary outcomes were changed after the publication of the protocol. For information on the outcomes we initially planned to assess see: <a href="#CD010784-sec-0179">Differences between protocol and review</a>. </p> <section id="CD010784-sec-0047"> <h6 class="title">Method and timing of outcome measurement</h6> <p> <ul id="CD010784-list-0004"> <li> <p>Stone‐free rate: defined as complete stone clearance or clinically insignificant residual fragments measuring less than 4 mm (a commonly used measure of 'success') (<a href="./references#CD010784-bbs2-0045" title="ParkH , ParkM , ParkT . Two‐year experience with ureteral stones: extracorporeal shockwave lithotripsy v ureteroscopic manipulation. Journal of Endourology1998;12(6):501‐4. ">Park 1998</a>). </p> </li> <li> <p>Serious adverse events or complications of treatment: defined by a Clavien‐Dindo classification of 3 or over (<a href="./references#CD010784-bbs2-0026" title="DindoD , DemartinesN , ClavienPA . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery2004;240(2):205‐13. ">Dindo 2004</a>). If the authors did not use the Clavien‐Dindo system, we will judge the adverse events by severity using the available information described in the studies. </p> </li> <li> <p>Secondary procedures for residual fragments measuring 4 mm or more (<a href="./references#CD010784-bbs2-0045" title="ParkH , ParkM , ParkT . Two‐year experience with ureteral stones: extracorporeal shockwave lithotripsy v ureteroscopic manipulation. Journal of Endourology1998;12(6):501‐4. ">Park 1998</a>). </p> </li> <li> <p>Hospital stay: measured in hours and days.</p> </li> <li> <p>Pain: measured by dose of medication, pain scale (e.g. visual analogue scale), or pain episodes. </p> </li> </ul> </p> <p>We used clinically important differences for the review outcomes to rate the quality of evidence for imprecision in the 'Summary of findings' tables (<a href="./references#CD010784-bbs2-0038" title="JohnstonBC , PatrickDL , BusseJW , SchünemannHJ , AgarwalA , GuyattGH . Patient‐reported outcomes in meta‐analyses—Part 1: assessing risk of bias and combining outcomes. Health and Quality of Life Outcomes2013;11:109. ">Johnston 2013</a>). When the mean difference (MD) or risk ratio (RR) was equal to or larger than the clinically important difference, we assumed that many patients may have gained clinically meaningful improvement from treatment; when the MD lies between 0.5 and 1.0 clinically important difference, an appreciable number of participants have likely achieved a clinically meaningful improvement; and when the MD falls below 0.5 clinically important difference, it is unlikely that an appreciable number of participants achieve clinically meaningful improvement (<a href="./references#CD010784-bbs2-0038" title="JohnstonBC , PatrickDL , BusseJW , SchünemannHJ , AgarwalA , GuyattGH . Patient‐reported outcomes in meta‐analyses—Part 1: assessing risk of bias and combining outcomes. Health and Quality of Life Outcomes2013;11:109. ">Johnston 2013</a>). No threshold was established for the SFR, serious adverse events or complications of treatment and secondary procedures. We considered the clinically important differences of all listed outcomes as a relative risk reduction of at least 25% (<a href="./references#CD010784-bbs2-0032" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines 6. Rating the quality of evidence—imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. ">Guyatt 2011a</a>). We used a clinically meaningful threshold of one day for length of hospital stay to assess efficacy and comparative effectiveness. As different measurement methods were used to assess pain related outcomes in the articles, we defined a clinically meaningful threshold for pain based on each measurement method (dose of medication, pain scale, pain episodes, and so on). </p> <section id="CD010784-sec-0048"> <p><b>Main outcomes for the 'Summary of findings' tables</b></p> <p>We assessed the following main outcomes, where available, in the following order of importance for the narrative 'Summary of findings' tables. </p> <p> <ul id="CD010784-list-0005"> <li> <p>Stone‐free rate.</p> </li> <li> <p>Serious adverse events or complications of treatment.</p> </li> <li> <p>Secondary procedures for residual fragments.</p> </li> <li> <p>Hospital stay.</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section id="CD010784-sec-0049"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010784-sec-0050"> <h4 class="title">Electronic searches</h4> <p>The search strategy was developed with the Cochrane Renal Group's Trials Search Co‐ordinator in 2012 and a search of the Cochrane Renal Group's Specialised Register was conducted. The latest search was conducted on 31 December 2017 of the databases detailed below. The search strategy terms used for the different databases are listed in <a href="./appendices#CD010784-sec-0170">Appendix 1</a>. The search strategy was conducted independently by two authors (LB, AA). The following electronic sources were used to identify relevant studies. </p> <p> <ul id="CD010784-list-0006"> <li> <p>Cochrane Central Register of Controlled trials (CENTRAL).</p> </li> <li> <p>MEDLINE (Ovid).</p> </li> <li> <p>Embase (Ovid).</p> </li> </ul> </p> <p>To identify RCTs and quasi‐RCTs we applied the Cochrane Highly Sensitive Search Strategy outlined in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). No language limitations were applied. See <a href="./appendices#CD010784-sec-0170">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD010784-sec-0051"> <h4 class="title">Searching other resources</h4> <p>We also searched the references of full articles retrieved for our review to identify any additional studies. To identify unpublished trials or trials in progress, we searched the following sources: ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) and the International Standard Randomised Controlled Trial Number registry (<a href="http://www.isrctn.com/" target="_blank">controlled‐trials.com</a>). We conducted a search of abstract proceedings of major urological and paediatric urology meetings, covering the years 2012 to 2017 (<a href="./appendices#CD010784-sec-0171">Appendix 2</a>). We contacted the authors of studies identified as potentially eligible to obtain clarification on missing data. </p> </section> </section> <section id="CD010784-sec-0052"> <h3 class="title" id="CD010784-sec-0052">Data collection and analysis</h3> <section id="CD010784-sec-0053"> <h4 class="title">Selection of studies</h4> <p>We used the search strategy described above to obtain titles and abstracts of studies that were relevant to the review. The titles and abstracts were screened independently by two review authors (LB, AA) on the basis of our inclusion and exclusion criteria. The two authors independently screened and assessed retrieved abstracts and discarded studies that were not applicable. The conflict resolution was performed by a third author (MK) independently. If resolution of a disagreement was not possible, we assigned the study as 'awaiting classification' and contacted study authors for clarification. We documented reasons for exclusion of studies that may have reasonably been expected to be included in the review in a <a href="./references#CD010784-sec-0183" title="">Characteristics of excluded studies</a> table. We presented an adapted PRISMA flow diagram showing the process of study selection (<a href="./references#CD010784-bbs2-0040" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJPA , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine2009;6(7):e1000100. [DOI: 10.1371/journal.pmed.1000100] ">Liberati 2009</a>). </p> </section> <section id="CD010784-sec-0054"> <h4 class="title">Data extraction and management</h4> <p>Data extraction was carried out independently by two authors (LB, MK) using modified data extraction forms created in Microsoft Excel. We extracted the following information, where available, which we provided in the <a href="./references#CD010784-sec-0182" title="">Characteristics of included studies</a> table. </p> <p> <ul id="CD010784-list-0007"> <li> <p>Study design.</p> </li> <li> <p>Study dates (if dates were not available then this was reported as such).</p> </li> <li> <p>Study settings and country.</p> </li> <li> <p>Participant inclusion and exclusion criteria.</p> </li> <li> <p>Participant details, baseline demographics.</p> </li> <li> <p>The number of participants by study and by study arm.</p> </li> <li> <p>Details of relevant experimental and comparator interventions such as SWL device.</p> </li> <li> <p>Definitions of relevant outcomes, method and timing of outcome measurement as well as any relevant subgroups. </p> </li> <li> <p>Study funding sources.</p> </li> <li> <p>Declarations of interest by primary investigators.</p> </li> </ul> </p> <p>We resolved any disagreements by discussion or, if required, by consultation with a third review author (AA). </p> <p>We attempted to contact authors of included studies to obtain important missing data as needed. </p> <section id="CD010784-sec-0055"> <h5 class="title">Dealing with duplicate and companion publications</h5> <p>In the event of duplicate publications, companion documents or multiple reports of a primary study, we obtained the maximum yield of information by mapping all publications to unique studies and collating all available data. The most complete data set aggregated across all known publications was used and in case of doubt, priority was given to the publication reporting the longest follow‐up associated with our primary or secondary outcomes. </p> </section> </section> <section id="CD010784-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias in the included studies for the following domains, in accordance with the Cochrane 'Risk of bias' tool (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>; <a href="./appendices#CD010784-sec-0172">Appendix 3</a>). </p> <p> <ul id="CD010784-list-0008"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study (detection bias)? </p> <ul id="CD010784-list-0009"> <li> <p>Participants and personnel</p> </li> <li> <p>Outcome assessors</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> <p>We judged risk of bias domains as 'low risk', 'high risk', or 'unclear risk' and evaluated individual bias items as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We presented a 'Risk of bias' summary figure to illustrate these findings. </p> <p>For selection bias (random sequence generation and allocation concealment), we have evaluated risk of bias at the trial level. </p> <p>We considered all outcomes as equally susceptible to performance bias (blinding of participants and personnel) and assessed them in one group. </p> <p>For detection bias (blinding of outcome assessment), we grouped outcomes as being either susceptible to detection bias (subjective outcomes) or not susceptible to detection bias (objective outcomes). </p> <p>We defined the following endpoints as subjective outcomes:</p> <p> <ul id="CD010784-list-0010"> <li> <p>stone‐free rate;</p> </li> <li> <p>serious adverse events or complications of treatment;</p> </li> <li> <p>pain.</p> </li> </ul> </p> <p>We defined the following endpoints as objective outcomes:</p> <p> <ul id="CD010784-list-0011"> <li> <p>secondary procedures for residual fragments;</p> </li> <li> <p>hospital stay.</p> </li> </ul> </p> <p>We also assessed attrition bias (incomplete outcome data) on an outcome‐specific basis, but created groups of outcomes based on similar reporting characteristics. </p> <p>For reporting bias (selective reporting), we evaluated risk of bias at the trial level. In the absence of an available protocol, we rated the risk of selective reporting as unclear. </p> <p>We further summarised the risk of bias across domains for each outcome in each included study, as well as across studies and domains for each outcome, in accordance with the approach for summary assessments of the risk of bias presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010784-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <p>We combined data from individual studies for meta‐analysis where interventions were similar enough. We expressed dichotomous outcome results (SFR, adverse events and complications after treatment, number of second procedures for residual fragments measuring 4 mm or more as RRs with 95% confidence intervals (CIs). We used the MD where continuous scales of measurement are used to assess the effects of treatment (mean hospital stay, pain scale, pain medication). </p> </section> <section id="CD010784-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant. In the event that we identified cross‐over trials, cluster‐randomised trials, or trials with more than two intervention groups for inclusion in the review, we handled these in accordance with guidance provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010784-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We sought to obtain missing data from study authors and performed intention‐to‐treat analyses if data were available; we otherwise performed available case analyses. We investigated attrition rates, e.g. dropouts, losses to follow‐up and withdrawals, and critically appraised issues of missing data. We did not impute missing data. </p> </section> <section id="CD010784-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was analysed using a Chi<sup>2</sup> test on N‐1 degrees of freedom with an alpha of 0.05 used for statistical significance and with the I<sup>2</sup> test (<a href="./references#CD010784-bbs2-0034" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). I<sup>2</sup> values of 25%, 50% and 75% generally correspond to low, medium and high levels of heterogeneity. However, this was interpreted in the given clinical context and also assessed for clinical significance. </p> <p>When we encountered heterogeneity, we attempted to determine possible reasons for it by examining individual study and subgroup characteristics. In the event of excessive heterogeneity unexplained by subgroup analyses, we planned not to report outcome results as the pooled effect estimate in a meta‐analysis but to provide a narrative description of the results of each study. </p> </section> <section id="CD010784-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to obtain study protocols to assess for selective outcome reporting.</p> <p>If we had included 10 studies or more investigating a particular outcome, we would have used funnel plots to assess small‐study effects. Several explanations can be offered for the asymmetry of a funnel plot, including true heterogeneity of effect with respect to trial size, poor methodological design (and hence bias of small trials) and publication bias. For these reasons, should we be able to create a funnel plot in future versions of this review, we will interpret it carefully. </p> </section> <section id="CD010784-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We summarised data using a random‐effects model. We interpreted random‐effects meta‐analyses with due consideration of the whole distribution of effects. We performed statistical analyses according to the statistical guidelines contained in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). For dichotomous outcomes, we used the Mantel‐Haenszel method; for continuous outcomes, we used the inverse variance method. We used Review Manager 5 software (<a href="./references#CD010784-bbs2-0048" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to perform all analyses. </p> </section> <section id="CD010784-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We expected the following characteristics to introduce clinical heterogeneity, and we planned to carry out subgroup analyses with investigation of interactions. </p> <p> <ul id="CD010784-list-0012"> <li> <p>Size of the kidney stone (less than 10 mm versus 10 mm or more).</p> </li> <li> <p>Location of the stone (renal pelvis versus ureter).</p> </li> </ul> </p> <p>These subgroup analyses are based on the following observations and European Association of Urology guidelines (<a href="http://uroweb.org/guideline/urolithiasis/" target="_blank">uroweb.org/guideline/urolithiasis/</a>). </p> <p> <ul id="CD010784-list-0013"> <li> <p>The selection of the procedure differs depending on the size of the stone (more than 20 mm: 1. PCNL, 2. retrograde renal surgery or SWL; 10 mm to 20 mm: SWL or endourology; less than 10 mm: 1. SWL or retrograde renal surgery, 2. PCNL). </p> </li> <li> <p>The selection of the procedure differs depending on the location of the stone (renal pelvis: PCNL, retrograde renal surgery or SWL; proximal ureter: SWL, ante‐ or retrograde ureteroscopy; distal ureter: ureteroscopy or SWL). </p> </li> </ul> </p> </section> <section id="CD010784-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses in order to explore the influence of the following factors (when applicable) on effect sizes. </p> <p> <ul id="CD010784-list-0014"> <li> <p>Restricting the analysis by taking into account risk of bias, by excluding studies at 'high risk' or 'unclear risk'. </p> </li> </ul> </p> <section id="CD010784-sec-0065"> <h5 class="title">'Summary of findings' table</h5> <p>We presented the overall quality of the evidence for each outcome according to the GRADE approach, which takes into account five criteria not only related to internal validity (risk of bias, inconsistency, imprecision, publication bias), but also to external validity, such as directness of results (<a href="./references#CD010784-bbs2-0031" title='GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , SchünemannHJ , et al. GRADE: what is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.)2008;336(7651):955‐8. [DOI: 10.1136/bmj.39490.551019.BE] '>Guyatt 2008</a>)<i>.</i> For each comparison, two review authors (LB, JHJ) independently rated the quality of evidence (QoE) for each outcome as 'high', 'moderate', 'low', or 'very low' using <a href="./references#CD010784-bbs2-0030" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2016. ">GRADEpro GDT</a>. We resolved any discrepancies by consensus, or, if needed, by arbitration by a third review author (AA). For each comparison, we presented a summary of the evidence for the main outcomes in a 'Summary of findings' table, which provides key information about the best estimate of the magnitude of the effect in relative terms and absolute differences for each relevant comparison of alternative management strategies; numbers of participants and studies addressing each important outcome; and the rating of the overall confidence in effect estimates for each outcome (<a href="./references#CD010784-bbs2-0033" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] ">Guyatt 2011b</a>; <a href="./references#CD010784-bbs2-0054" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Schünemann 2011</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010784-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010784-sec-0066"></div> <section id="CD010784-sec-0067"> <h3 class="title">Description of studies</h3> <p>For a detailed description of studies see <a href="#CD010784-tbl-0008">Table 1</a>, <a href="./references#CD010784-sec-0182" title="">Characteristics of included studies</a> and <a href="./references#CD010784-sec-0183" title="">Characteristics of excluded studies</a>. </p> <div class="table" id="CD010784-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of the interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) appropriate as applied in a clinical practice setting<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparator(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparator(s) appropriate as applied in a clinical practice setting<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] "><b>Aghamir 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Puncture was performed in the prone position by 18‐gauge nephrostomy needle, under fluoroscopic guidance the tract was dilated by coaxial serial metallic dilators, an Amplatz sheath up to 28 F, and up to 26 F Storz nephroscope was used, the stone fragmentation was performed with a pneumatic lithotripter (EMS Swiss lithoclast) and residual stones were extracted with a grasper, both ureteral stent and the working sheath were removed at the end of procedure without placing any nephrostomy tube. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Puncture was performed in the prone position by 18‐gauge nephrostomy needle, under fluoroscopic guidance the tract was dilated by coaxial serial metallic dilators, an Amplatz sheath up to 28 F, and up to 26 F Storz nephroscope was used, the stone fragmentation was performed with a pneumatic lithotripter (EMS Swiss lithoclast) and residual stones were extracted with a grasper, ureteral stent was remained and a nephrostomy tube was placed through the working sheath for 24–48 hours. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. "><b>Aldaquadossi 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: alpha‐1 blocker (tamsulosin) therapy in addition to ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsulosin 0.4 mg for patients aged &gt; 5 years and 0.2 mg for younger children and Ibuprofen 4–10 mg/kg orally every 6–8 h as needed. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Ibuprofen only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen 4–10 mg/kg orally every 6–8 h as needed.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] "><b>Aydogdu 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen (20 mg/kg daily divided into 2 equal doses).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Doxazosin and ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen (20 mg/kg daily divided into 2 equal doses) and doxazosin dose was approximately 0.03 mg/kg once daily. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] "><b>Basiri 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Transureteral lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients were placed in the lithotomy position and a 6 Fr or 8.5 Fr semirigid ureteroscope was passed into the ureter using a safety guidewire, the ureteral calculus fragmentation was performed with holmium laser or pneumatic lithotripsy. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shock wave was delivered by under‐table Compact Delta II electromagnetic sources, with patients in the prone position under ultrasound or fluoroscopic guidance, impulse rate per treatment varied from 1,250 to 2,400 (mean 1,530) and power ranged from 11 to 13 kV. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] "><b>De Domenicis 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ureteroscopy plus intracorporeal lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For ureteroscopy the 7.5 F ureteroscope with a 5 F operative channel was used (Storz, Germany) and the Lithoclast® ballistic lithotripter (1.9 F tapered semiflexible probe) or holmium‐YAG laser (400 mm fibres) was used for disintegrating the stones in the distal ureter, patient in the dorsal lithotomy position, paediatric cystoscope was used to place a 4.8 F open‐ended catheter to the level of the intramural ureter, and a low‐pressure retrograde ureteropyelogram was done, a 0.9 mm PTFE guidewire was used as a safety wire, the second/ working guidewire was used for insertion of the ureteroscope, ureteric dilators (6–9 F) were used in two cases, the semiflexible probe of the Lithoclast or laser fibre was used for the lithotripsy. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Extracorporeal shock wave<br/> lithotripsy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EDAP‐Sonolith 4000 + lithotripter was used in prone prone position, ≈2500 shock waves (1900–3500) were delivered, usually at 450 KJ (330–694), ureteric open‐ended catheter was left in place and removed in the next 24–72 h. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. "><b>Elderwy 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Dissolution therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral potassium sodium hydrogen citrate was administered at a dose of 1 mEq/kg per day in 2 or 3 divided doses after meals for 1 to 3 months. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lithotripter S was used, a total count of 2,000 shock waves per session at 12 to 14 kV power and a frequency of 60 to 70 per minute. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. "><b>Elgalaly 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silodosin 4 mg at bedtime. Ibuprofen<br/> (20 mg/kg/day) was divided into two doses for pain episodes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo at bedtime. Ibuprofen (20 mg/kg/day) was divided into two doses for pain episodes.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] "><b>Erturhan 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen 20 mg/kg/d divided into 2 equal doses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: alpha‐1 blocker (doxazosin) therapy in addition to ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen 20 mg/kg/d divided into 2 equal doses and 0.03 mg/kg/d doxazosin once daily, before bed. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. "><b>Fahmy 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 mg silodosin daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Tamsuosin or placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsulosin group 0.4 mg tamsulosin daily, placebo group were not given any medications.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. "><b>Gamal 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Flexible ureteroscopy plus lasertripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A 7.5 Fr flexible ureteroscope (FURS) was introduced into the ureter over a hydrophilic guidewire under visual and fluoroscopic guidance without access sheath. Complete stone dusting using 200 mm laser fiber (0.2‐1.0 joules power and15‐30 Hz frequency) was done in all cases ending with a 5 Fr JJ stent insertion. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. "><b>Kumar 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Mini percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5F open‐ended ureteral catheter was placed in the renal pelvis cystoscopically, anatomy of the pelvicaliceal system was assessed by infusing contrast media via the ureteral catheter, selected calix was punctured under fluoroscopy guidance by an 18‐gauge needle using the ‘‘bulls eye technique,’’ the tract was dilated to 18F, 15F miniature nephroscope (Richard Wolf, Vernon Hills, IL) was used with pneumatic intracorporeal lithotripsy, stone fragmentation and clearance were confirmed by direct vision and under fluoroscopy, 12F nephrostomy tube, kept in situ for drainage, was removed once urine was clear. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 minutes before the procedure 5 gm of a eutectic mixture of lidocaine and prilocaine was applied on approximately 30 cm2 area of skin corresponding to the site of entry of shockwaves electromagnetic lithotripter (Dornier Alpha Compact system, Wessling, Germany), the shockwave delivery rate was 90 pulses per minute, the maximum number of shockwaves was 2500 per session. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] "><b>Mokhless 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tamsulosin and standard analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsulosin 0.4 mg for children older than 4 years and 0.2 mg for younger children at bed time in addition to standard analgesia (ibuprofen). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo and standard analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard analgesia (ibuprofen) and placebo.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. "><b>Salem 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Slow delivery rate shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Using the Dornier Lithotripter S (Dornier Medical Systems, Kennesaw, Georgia) with the 220 electromagnetic shock wave emitter, fluoroscopy was used for stone localisation, energy was increased gradually from 14 to 20 kV, in children younger than 4 years the energy was increased to 18 kV, 80 shock waves per minute were used, maximum number of shock waves delivered was 2,500. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Rapid delivery rate shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Using the Dornier Lithotripter S (Dornier Medical Systems, Kennesaw, Georgia) with the 220 electromagnetic shock wave emitter, fluoroscopy was used for stone localisation, energy was increased gradually from 14 to 20 kV, in children younger than 4 years the energy was increased to 18 kV, 120 shock waves per minute were used, maximum number of shock waves delivered was 2,500. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. "><b>Song 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless mini‐percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>F4 ureteral catheter inserted into the affected renal pelvis through the paediatric cystoscope, Foley catheter was placed and fixed to the ureteral catheter with surgical threads, sterile saline was flushed into the kidney through the ureteral catheter to create an artificial hydronephrosis, 18G biopsy needle was inserted to the targeted renal pelvis, ureteral catheter was expanded by fascia dilator to F14 or F16 while the sheath was left in place, paediatric nephroscope or ureteroscope was inserted and stones fragmented by holmium laser, fragments were picked or washed out by lavage fluid, residual stones were removed completely or the second nephrostomy access tract for lithotripsy was selected for<br/> complete clearance. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>F4 ureteral catheter inserted into the affected renal pelvis through the paediatric cystoscope, Foley catheter was placed and fixed to the ureteral catheter with surgical threads, sterile saline was flushed into the kidney through the ureteral catheter to create an artificial hydronephrosis, 18G biopsy needle was inserted to the targeted renal pelvis, ureteral catheter was expanded by fascia dilator to F14 or F16 while the sheath was left in place, paediatric nephroscope or ureteroscope was inserted and stones fragmented by holmium laser, fragments were picked or washed out by lavage fluid, residual stones were removed completely or the second nephrostomy access tract for lithotripsy was selected for complete clearance, the nephrostomy tube was removed 24 hours later. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>‐ denotes not reported</p> <p><sup>a</sup>The term 'clinical practice setting' refers to the specification of the intervention/comparator as used in the course of a standard medical treatment (such as dose, dose escalation, dosing scheme, provision for contraindications and other important features). </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>C</b> : comparator; <b>I</b> : intervention; <b>IL</b> : Illinois;<b>h</b> : hours <b>PTFE</b> : polytetrafluoroethylen; <b>YAG</b>: yattrium aluminium garnet. </p> </div> </div> <section id="CD010784-sec-0068"> <h4 class="title">Results of the search</h4> <p>We identified a total of 700 references from all searches; after removing duplicates, we screened 617 titles. After screening titles we excluded a further 541 references; we then reviewed the abstracts of 76 references. This led to us excluding a further 55 references and retrieving full‐text articles for 21 studies. After review of the full‐text articles, we excluded seven studies. A total of 14 studies were included in the final review. The flow of studies identified to be included in the review is summarised in a flow chart (<a href="#CD010784-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010784-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram." data-id="CD010784-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> </div> </section> <section id="CD010784-sec-0069"> <h4 class="title">Included studies</h4> <p>A detailed description of the characteristics of included studies is presented elsewhere (see <a href="./references#CD010784-sec-0182" title="">Characteristics of included studies</a>). The following is a succinct overview. </p> <section id="CD010784-sec-0070"> <h5 class="title">Source of data</h5> <p>The data presented in the review are obtained from published literature. We identified 14 trials as eligible for inclusion. Surgical and medical interventions are assessed in the various studies (see <a href="#CD010784-tbl-0008">Table 1</a>). </p> </section> <section id="CD010784-sec-0071"> <h5 class="title">Comparisons</h5> <p>Seven of the trials compared surgical interventions (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). Six trials compared medical intervention (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>) and one trial compared medical versus surgical intervention (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>) (see <a href="#CD010784-tbl-0009">Table 2</a>). </p> <div class="table" id="CD010784-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention (duration of follow‐up)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] "><b>Aghamir 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 24‐48 hours after surgery, one week and one month after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 14 years old, renal stone &gt; 2.5 cm or renal stone with lesser diameter, and extracorporeal shockwave lithotripsy failure </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2010‐2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. "><b>Aldaquadossi 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: alpha‐1 blocker (tamsulosin) therapy in addition to ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: weekly for 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Group 1: 33 children ‐ mean age 7.7 years; group 2: 34 children ‐ mean age 7.25 years, distal ureteric stone of &lt; 1 cm, and below the common iliac vessels </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2010‐2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Ibuprofen only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] "><b>Aydogdu 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 19 days (mean)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2‐14 years old, radio‐opaque lower ureteral stone 2‐10 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2005‐2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Doxazosin and ibuprofen</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] "><b>Basiri 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Transureteral lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 2 weeks postoperatively with ultrasound, another at 3 months with excretory urography (more frequent if persistent stone present) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1‐13 years old, distal ureteral calculi 15‐56 mm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2007‐2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shock wave lithotripsy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] "><b>De Domenicis 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ureteroscopy plus intracorporeal lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 6‐8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2‐17 years old, radio‐opaque calculi in distal ureter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1 year (time range not specified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Extracorporeal shock wave<br/> lithotripsy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. "><b>Elderwy 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Dissolution therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: every 3‐4 weeks and every 3‐4 months thereafter</p> <p>length of treatment: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.5‐13 years old, renal calculi 7‐24 mm &lt; 500 HU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2010‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard shock wave lithotripsy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. "><b>Elgalaly 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: history, physical examination, urine analysis, KUB, ultrasonography at 2 and 4 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 18 years old, single unilateral radiopaque DUS, and largest stone diameter of ≤ 10 mm </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2014‐2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hopsital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] "><b>Erturhan 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: for 3 weeks with weekly examinations</p> <p>length of treatment: 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3‐15 years old, lower ureteral stones (group 1: 4.45 ± 1.5 mm, group 2: 4.58 ± 1.7 mm) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>not disclosed in the study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hopsital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: alpha‐1 blocker (doxazosin) therapy in addition to ibuprofen</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. "><b>Fahmy 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: stone free rate assessed after 4 weeks. Further details of follow up not supplied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 18 years old, unilateral, single, radio‐opaque distal ureteral stones &lt; 10 mm in size </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hopsital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Tamsuosin or placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. "><b>Gamal 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Flexible ureteroscopy plus lasertripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: stone free rate assessed after 1 month. Further details of follow up not supplied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 15 years old, with a renal stones (1‐2) cm in a solitary kidney</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2011‐2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. "><b>Kumar 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Mini percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 15 years old, single lower caliceal stone 1‐2 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2012‐2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] "><b>Mokhless 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tamsulosin and standard analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: close for 4 weeks</p> <p>Length of treatment: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2‐15 years old, distal ureteric calculi &lt; 12 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2007‐2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo and standard analgesia</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. "><b>Salem 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Slow delivery rate shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 2 and 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3‐14 years old, renal calculi 10‐20 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2011‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Rapid delivery rate shock wave lithotripsy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. "><b>Song 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless mini‐percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 1, 3, 6, 12 months postoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7‐36 months old, renal stones with cumulative diameter &lt; 4.5 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2009‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>If a field is left empty, the study did not contain the required information.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>KUB</b>: kidney, ureter, and bladder. </p> </div> </div> </section> <section id="CD010784-sec-0072"> <h5 class="title">Overview of trial populations</h5> <p>The 14 studies included a total of 978 participants. Individual sample sizes ranged from 22 to 221 participants. </p> <p>The seven trials of surgical interventions included a total of 535 participants (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). Two groups of 263 and 272 surgical patients were compared. </p> <p>The six trials of medical interventions included a total of 347 participants (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). There was a total of 158 participants in the intervention arm and 189 in the control arm. Five participants did not complete one of the trials and were not included in their group analysis (<a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>). </p> <p>The medical versus surgical group included 96 participants and 87 completed the study (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>). The medical intervention group had 48 participants and the surgical intervention group 39 participants. </p> </section> <section id="CD010784-sec-0073"> <h5 class="title">Trial design</h5> <p>Thirteen studies were RCTs and one had a quasi‐randomised design (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>). Trials were performed in the years ranging from July 2002 until 2017. The number of study centres in all studies ranged from a single centre to six. Two of the 14 trials were Multicentre (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>), one surgical (which took place in seven centres) and one medical intervention study (not detailed). Only one out of the four medical therapy trials included a placebo. All surgical‐only trials included a two‐arm study group with a surgical intervention as comparator. Duration of follow‐up ranged from one week to one year. </p> </section> <section id="CD010784-sec-0074"> <h5 class="title">Settings</h5> <p>Ten trials were conducted in the hospital setting (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>), one in the hospital outpatient setting (<a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>), and three in a mixed hospital and outpatient setting (<a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). </p> </section> <section id="CD010784-sec-0075"> <h5 class="title">Participants</h5> <p>The mean age of trial participants ranged from 20.3 months to 11.1 years (with an age range of 0.5 to 17 years). Ethnic groups were not described, however two studies were conducted in Turkey (<a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>), seven studies in Egypt (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>), two studies in Iran (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>), one in India (<a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>), one in China (<a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>), and one in Italy (<a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>). Major exclusion criteria were renal abnormalities and coagulopathy; individual exclusion criteria are detailed in the <a href="./references#CD010784-sec-0182" title="">Characteristics of included studies</a> table. Inclusion criteria related to stone size and age. In the surgical group, stone size range was 5 mm to 45 mm (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). In the medical therapy group, stone size ranged from 2 mm to 12 mm (<a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>), and less than 1 cm in <a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>. In the medical and surgical intervention group the median stone size was 12 mm (10 mm to 16 mm) (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>). </p> </section> <section id="CD010784-sec-0076"> <h5 class="title">Diagnosis</h5> <p>Imaging (kidneys ureters bladder ultrasound, kidneys ureters bladder radiograph and/or CT scan was the modality of choice for confirming the diagnosis and clearance of renal stones in all studies. </p> </section> <section id="CD010784-sec-0077"> <h5 class="title">Interventions</h5> <p>In the surgical group, interventions were SWL, retrograde ureteroscopy, PCNL, mini‐PCNL, tubeless PCNL, and tubeless mini‐PCNL, mini‐PCNL (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). </p> <p>In the study comparing medical with surgical intervention, potassium sodium hydrogen citrate (at a dose of 1 mEq/kg per day) was administered orally for one to three months to the medical group whilst the surgical group were treated with the Lithotripter S (Dornier Medtech, Kennesaw, Georgia) under general anaesthesia (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>). </p> <p>In the medical group the intervention was the use of an alpha blocker: doxazosin (0.03 mg/Kg) in two studies, tamsulosin (0.4 mg in those over four years of age and 0.2 mg in those under two years of age) in two studies, and silodosin (8 mg) (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). Two of these studies included a placebo (<a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). One of these studies (<a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>) compared two interventions (tamsulosin and silodosin) and placebo. </p> </section> <section id="CD010784-sec-0078"> <h5 class="title">Outcomes</h5> <p>The most commonly defined outcome in the publications was SFR. There were different definitions of SFR across the studies. Two studies considered SFR as fragments less than or equal to 4 mm (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>), and one as fragments less than 3 mm (<a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>). All other studies defined SFR as complete clearance of stones. All included studies were assessed for adverse events and the need for second procedures. Complications were reported in seven studies (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). The rate of secondary procedures was reported in eight studies (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). Hospital stay was included in five studies (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). Pain requiring analgesia or being documented as 'pain episodes' was included in three studies (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). </p> <p>While all studies reported SFRs, only seven studies reported serious adverse events or complications of treatments. This limits the application of the information at the point of care or in clinical practice guidelines. </p> </section> <section id="CD010784-sec-0079"> <h5 class="title">Funding source and conflicts of interests</h5> <p>Three studies declared no conflict of interest (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). No funding source was reported in five studies (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). </p> </section> </section> <section id="CD010784-sec-0080"> <h4 class="title">Excluded studies</h4> <p>We excluded four of five trials after evaluation of the full publication. The main reasons for exclusion are detailed in the tables of <a href="./references#CD010784-sec-0183" title="">Characteristics of excluded studies</a>. </p> <section id="CD010784-sec-0081"> <h5 class="title">Studies awaiting classification and ongoing trials</h5> <p>We did not identify any studies as awaiting classification, nor did we identify any ongoing trials. </p> </section> </section> </section> <section id="CD010784-sec-0082"> <h3 class="title">Risk of bias in included studies</h3> <p>Assessments of risk of bias are summarised in <a href="#CD010784-fig-0002">Figure 2</a> and <a href="#CD010784-fig-0003">Figure 3</a>. Judgement of individual domains are discussed below. </p> <div class="figure" id="CD010784-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD010784-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010784-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD010784-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD010784-sec-0083"> <h4 class="title">Allocation</h4> <section id="CD010784-sec-0084"> <h5 class="title">Random sequence generation</h5> <p>Six of the 14 studies describe randomisation with adequate sequence generation (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>), leading to a low risk of bias. We judged one study, which employed quasi‐randomisation by month of presentation, as having a high risk of bias (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>). The remaining studies did not provide information on sequence generation, leading to an unclear risk of bias. </p> </section> <section id="CD010784-sec-0085"> <h5 class="title">Allocation concealment</h5> <p>We judged only one study, which used opaque, sealed and numbered envelopes, as having a low risk of bias (<a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>). Other trials did not describe an adequate method of allocation concealment and we judged them as having unclear risk of bias in this domain. </p> </section> </section> <section id="CD010784-sec-0086"> <h4 class="title">Blinding</h4> <section id="CD010784-sec-0087"> <h5 class="title">Blinding of participants and personnel</h5> <p>We rated one study as 'low risk of bias' and three studies as 'high risk of bias' (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>). Other trials did not describe an adequate method for blinding participants and personnel and we judged them as having an unclear risk of bias. </p> </section> <section id="CD010784-sec-0088"> <h5 class="title">Blinding of outcome assessment</h5> <p> <ul id="CD010784-list-0015"> <li> <p>Blinding of subjective outcomes (SFR, serious adverse events or complications of treatment, pain): we judged two studies as having low risk of bias (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>) and one study as having high risk of bias (<a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>). Other trials did not describe an adequate method and we judged them as having unclear risk of bias. </p> </li> <li> <p>Blinding of objective outcomes (secondary procedures for residual fragments, hospital stay): we rated all trials as 'low risk of bias' due to the objective nature of the outcomes. </p> </li> </ul> </p> </section> </section> <section id="CD010784-sec-0089"> <h4 class="title">Incomplete outcome data</h4> <p> <ul id="CD010784-list-0016"> <li> <p>SFR: we rated nine studies as 'low risk of bias' (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>) and two studies as 'high risk of bias' (<a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>). The remaining studies were rated as 'unclear risk of bias'. </p> </li> <li> <p>Serious adverse events or complications of treatment: we rated eight studies as 'low risk of bias' (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>) and one study as 'high risk of bias' (<a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>). The remaining studies were rated as 'unclear risk of bias'. </p> </li> <li> <p>Secondary procedures for residual fragments: we rated seven studies as 'low risk of bias' (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>; <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>). The remaining studies were rated as 'unclear risk of bias'. </p> </li> <li> <p>Hospital stay: we rated five studies as 'low risk of bias' (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). The remaining studies were rated as 'unclear risk of bias'. </p> </li> <li> <p>Pain: we rated three studies as 'low risk of bias' (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>) and one study as 'high risk of bias' (<a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>). The remaining were rated as 'unclear risk of bias'. </p> </li> </ul> </p> </section> <section id="CD010784-sec-0090"> <h4 class="title">Selective reporting</h4> <p>We rated five studies as 'high risk of bias' due to inappropriate exclusion of participants with adverse events (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>) and no prespecification of study outcomes with no available protocols (<a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>). The others were rated as 'unclear risk of bias' due to there being no available protocols. </p> </section> <section id="CD010784-sec-0091"> <h4 class="title">Other potential sources of bias</h4> <p>We considered the risk of reporting bias to be low in 10 studies (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>; <a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). We judged <a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a> to be at high risk of bias due to baseline imbalance. The other trials appeared to have an unclear risk of bias due to the possibility of difference in follow‐up (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>) and insufficient information (abstract only: <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>). </p> </section> </section> <section id="CD010784-sec-0092"> <h3 class="title" id="CD010784-sec-0092">Effects of interventions</h3> <p>See: <a href="./full#CD010784-tbl-0001"><b>Summary of findings for the main comparison</b> Shock wave lithotripsy versus dissolution therapy for renal stones</a>; <a href="./full#CD010784-tbl-0002"><b>Summary of findings 2</b> Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</a>; <a href="./full#CD010784-tbl-0003"><b>Summary of findings 3</b> Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones</a>; <a href="./full#CD010784-tbl-0004"><b>Summary of findings 4</b> Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</a>; <a href="./full#CD010784-tbl-0005"><b>Summary of findings 5</b> Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</a>; <a href="./full#CD010784-tbl-0006"><b>Summary of findings 6</b> Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</a>; <a href="./full#CD010784-tbl-0007"><b>Summary of findings 7</b> Alpha‐blockers versus placebo with/without analgesics</a> </p> <section id="CD010784-sec-0093"> <h4 class="title">1. Shock wave lithotripsy versus dissolution therapy for intrarenal stones</h4> <p>We found a single study with 87 participants (39 randomised to SWL and 48 to oral citrate) (<a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. ">Elderwy 2014</a>). The follow‐up period was three months. See <a href="./full#CD010784-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD010784-sec-0094"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0095"> <h6 class="title">1.1 Stone‐free rate</h6> <p>We are uncertain about the effects of SWL on SFR (RR 1.13, 95% CI 0.90 to 1.41; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> <section id="CD010784-sec-0096"> <h6 class="title">1.2 Serious adverse events or complications of treatment</h6> <p>We are uncertain about the effects of SWL on serious adverse events (RR 1.23, 95% CI 0.08 to 19.05; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> <section id="CD010784-sec-0097"> <h6 class="title">1.3 Secondary procedures for residual fragments</h6> <p>We are uncertain about the effects of SWL on secondary procedures for residual fragments (RR 0.66, 95% CI 0.29 to 1.50; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> </section> <section id="CD010784-sec-0098"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0099"> <h6 class="title">1.4 Hospital stay</h6> <p>We did not find data related to hospital stay.</p> </section> <section id="CD010784-sec-0100"> <h6 class="title">1.5 Pain</h6> <p>We did not find data related to pain.</p> </section> </section> <section id="CD010784-sec-0101"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <p>We were unable to produce any preplanned secondary analyses due to the lack of suitable data. </p> </section> </section> <section id="CD010784-sec-0102"> <h4 class="title">2. Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</h4> <p>We found a single study with 60 participants (30 randomised to slow SWL and 30 randomised to rapid SWL) (<a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. ">Salem 2014</a>). The follow‐up period was a minimum of one month. See <a href="./full#CD010784-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD010784-sec-0103"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0104"> <h6 class="title">2.1 Stone‐free rate</h6> <p>We are uncertain about the effects of slow SWL on SFR (RR 2.25, 95% CI 1.16 to 4.36; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> <section id="CD010784-sec-0105"> <h6 class="title">2.2 Serious adverse events or complications of treatment</h6> <p>We could not estimate the risk of serious adverse events or complications of treatment due to there being no reported events. </p> </section> <section id="CD010784-sec-0106"> <h6 class="title">2.3 Secondary procedures for residual fragments</h6> <p>We are uncertain about the effects of slow SWL on secondary procedures for residual fragments (RR 0.38, 95% CI 0.11 to 1.28; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> </section> <section id="CD010784-sec-0107"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0108"> <h6 class="title">2.4 Hospital stay</h6> <p>We did not find data related to hospital stay.</p> </section> <section id="CD010784-sec-0109"> <h6 class="title">2.5 Pain</h6> <p>We did not find data related to pain.</p> </section> </section> <section id="CD010784-sec-0110"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <p>We were unable to conduct any preplanned secondary analyses due to the lack of suitable data. </p> </section> </section> <section id="CD010784-sec-0111"> <h4 class="title">3. Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones </h4> <p>We found three studies with 153 participants (75 randomised to SWL and 78 randomised to ureteroscopy) (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>; <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>). All studies were included in the analyses, except for the outcome 'hospital stay' which included data from <a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a> and <a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>. While two studies reported the follow‐up period (two weeks to eight months) (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>), one (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>) did not report the period. See <a href="./full#CD010784-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD010784-sec-0112"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0113"> <h6 class="title">3.1 Stone‐free rate</h6> <p>We are uncertain about the effects of SWL on SFR (RR 0.62, 95% CI 0.43 to 0.88; very low‐quality evidence). We downgraded for study limitations, indirectness, and imprecision. </p> </section> <section id="CD010784-sec-0114"> <h6 class="title">3.2 Serious adverse events or complications of treatment</h6> <p>We are uncertain about the effects of SWL on severe adverse events (RR 0.56, 95% CI 0.12 to 2.58; very low‐quality evidence). We downgraded for study limitations, indirectness, and imprecision. </p> </section> <section id="CD010784-sec-0115"> <h6 class="title">3.3 Secondary procedures for residual fragments</h6> <p>We are uncertain about the effects of SWL on secondary procedures (RR 3.47, 95% CI 1.32 to 9.15; very low‐quality evidence). We downgraded for study limitations, indirectness, and imprecision. </p> </section> </section> <section id="CD010784-sec-0116"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0117"> <h6 class="title">3.4 Hospital stay (hours)</h6> <p>We are uncertain about the effects of SWL on hospital stay (MD ‐10.71, 95% CI ‐34.09 to 12.67; very low‐quality evidence). We downgraded for study limitations, indirectness, and imprecision. </p> </section> <section id="CD010784-sec-0118"> <h6 class="title">3.5 Pain</h6> <p>We did not find any data related to pain.</p> </section> </section> <section id="CD010784-sec-0119"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <section id="CD010784-sec-0120"> <h6 class="title">1. Size of the kidney stone (less than 10 mm versus 10 mm or more)</h6> <p>We were unable to conduct any preplanned secondary analyses due to the lack of suitable data. </p> </section> <section id="CD010784-sec-0121"> <h6 class="title">2. Location of the stone (renal pelvis versus ureter)</h6> <p> <ul id="CD010784-list-0017"> <li> <p>SFR: we found a RR of 0.50 (95% CI 0.25 to 0.98) in the participants with renal stones (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>) versus a RR of 0.63 (95% CI 0.39 to 1.03) in the participants with distal ureteral stone (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>). The test for interaction was not significant (P = 0.57, I<sup>2</sup> = 0%). </p> </li> <li> <p>Serious adverse events or complications of treatment: we found a RR of 0.33 (95% CI 0.02 to 7.39) in the participants with renal stones (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>) versus a RR of 0.67 (95% CI 0.12 to 3.82) in the participants with distal ureteral stones (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>). The test for interaction was not significant (P = 0.70, I<sup>2</sup> = 0%). </p> </li> <li> <p>Secondary procedures for residual fragments: we found a RR of 6.00 (95% CI 0.86 to 41.96) in the participants with renal stones (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>) versus a RR of 3.46 (95% CI 0.82 to 14.58) in the participants with distal ureteral stones (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>; <a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] ">De Domenicis 2005</a>). The test for interaction was not significant (P = 0.66, I<sup>2</sup> = 0%). </p> </li> <li> <p>Hospital stay (hours): we found an MD of 0.00 (95% CI −1.07 to 1.07) in the participants with renal stones (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a>) versus an MD of −24.00 (95% CI ‐39.45 to ‐8.55) in the participants with distal ureteral stones (<a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] ">Basiri 2010</a>). The test for interaction was significant (P = 0.002, I<sup>2</sup> = 89.2%). </p> </li> </ul> </p> </section> </section> </section> <section id="CD010784-sec-0122"> <h4 class="title">4. Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</h4> <p>We found a single study with 221 participants (110 randomised to SWL and 111 randomised to mini‐PCNL) (<a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. ">Kumar 2015</a>). The follow‐up period was three months. See <a href="./full#CD010784-tbl-0004">summary of findings Table 4</a>. </p> <section id="CD010784-sec-0123"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0124"> <h6 class="title">4.1 Stone‐free rate</h6> <p>SWL likely has lower SFR (RR 0.88, 95% CI 0.80 to 0.97), but this may not represent a clinically important difference and is based on moderate‐quality evidence. SWL would result in 113 fewer stone‐free patients per 1000 (189 fewer to 28 fewer). We downgraded for study limitations. </p> </section> <section id="CD010784-sec-0125"> <h6 class="title">4.2 Serious adverse events or complications of treatment</h6> <p>SWL may reduce severe adverse events (RR 0.13, 95% CI 0.02 to 0.98; low‐quality evidence). This corresponds to 66 fewer serious adverse events or complications per 1000 (74 fewer to 2 fewer). We downgraded for study limitations and imprecision. </p> </section> <section id="CD010784-sec-0126"> <h6 class="title">4.3 Secondary procedures for residual fragments</h6> <p>SWL may increase the need of secondary procedures (RR 2.50, 95% CI 1.01 to 6.20; low‐quality evidence). SWL would result in 85 more secondary procedures per 1000 (1 more to 294 more). We downgraded for study limitations and imprecision. </p> </section> </section> <section id="CD010784-sec-0127"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0128"> <h6 class="title">4.4 Hospital stay (days)</h6> <p>SWL likely reduces hospital stay (MD ‐3.40, 95% CI ‐5.43 to ‐1.37; moderate‐quality evidence). We downgraded for study limitations. </p> </section> <section id="CD010784-sec-0129"> <h6 class="title">4.5 Pain</h6> <p>We did not find any data related to pain.</p> </section> </section> <section id="CD010784-sec-0130"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <p>We were unable to conduct any preplanned secondary analyses due to the lack of suitable data. </p> </section> </section> <section id="CD010784-sec-0131"> <h4 class="title">5. Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones </h4> <p>We found a single study with 23 participants (10 randomised to PCNL and 13 randomised to tubeless PCNL) (<a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] ">Aghamir 2012</a>). The follow‐up period was one month. See <a href="./full#CD010784-tbl-0005">summary of findings Table 5</a>. </p> <section id="CD010784-sec-0132"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0133"> <h6 class="title">5.1 Stone‐free rate</h6> <p>We are uncertain about the effect of PCNL in SFR (RR 1.16, 95% CI 0.88 to 1.53; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> <section id="CD010784-sec-0134"> <h6 class="title">5.2 Serious adverse events or complications of treatment</h6> <p>We are uncertain about the effect of PCNL on serious adverse events (RR 0.42, 95% CI 0.02 to 9.43; very low quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> <section id="CD010784-sec-0135"> <h6 class="title">5.3 Secondary procedures for residual fragments</h6> <p>We are uncertain about the effect of PCNL on secondary procedures (RR 0.42, 95% CI 0.02 to 9.43; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> </section> <section id="CD010784-sec-0136"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0137"> <h6 class="title">5.4 Hospital stay (hours)</h6> <p>PCNL may increase hospital stay (MD 19.16, 95% CI 10.24 to 28.08; low‐quality evidence). We downgraded for study limitations and serious imprecision. </p> </section> <section id="CD010784-sec-0138"> <h6 class="title">5.5 Pain (dose of morphine: mg/kg)</h6> <p>PCNL likely requires larger doses of morphine (MD 0.08 , 95% CI 0.05 to 0.11; moderate‐quality evidence). We downgraded for study limitations. </p> </section> </section> <section id="CD010784-sec-0139"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <p>We were unable to conduct any preplanned secondary analyses due to the lack of suitable data. </p> </section> </section> <section id="CD010784-sec-0140"> <h4 class="title">6. Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones </h4> <p>We found a single study with 78 participants (38 randomised to PCNL and 40 randomised to tubeless mini‐PCNL) (<a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. ">Song 2015</a>). The follow‐up period was 12 months. See <a href="./full#CD010784-tbl-0006">summary of findings Table 6</a>. </p> <section id="CD010784-sec-0141"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0142"> <h6 class="title">6.1 Stone‐free rate</h6> <p>PCNL likely results in no difference in SFR (RR 1.03, 95% CI 0.93 to 1.14; moderate‐quality evidence). PCNL would result in 28 more stone‐free patients per 1,000 (66 fewer to 132 more). We downgraded for study limitations. </p> </section> <section id="CD010784-sec-0143"> <h6 class="title">6.2 Serious adverse events or complications of treatment</h6> <p>We did not find any data related to serious adverse events.</p> </section> <section id="CD010784-sec-0144"> <h6 class="title">6.3 Secondary procedures for residual fragments</h6> <p>We were unable to estimate the risk of secondary procedures due to there being no reported events. </p> </section> </section> <section id="CD010784-sec-0145"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0146"> <h6 class="title">6.4 Hospital stay (days)</h6> <p>PCNL likely increases hospital stay (MD 3.14, 95% CI 2.78 to 3.50; moderate‐quality evidence). We downgraded for study limitations. </p> </section> <section id="CD010784-sec-0147"> <h6 class="title">6.5 Pain</h6> <p>We did not find any data related to pain.</p> </section> </section> <section id="CD010784-sec-0148"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <p>We were unable to conduct any preplanned secondary analyses due to the lack of suitable data. </p> </section> </section> <section id="CD010784-sec-0149"> <h4 class="title">7. Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones</h4> <p>We found six studies with a different number of participants in each analysis (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). The follow‐up period ranged from three to four weeks. See <a href="./full#CD010784-tbl-0007">summary of findings Table 7</a>. </p> <section id="CD010784-sec-0150"> <h5 class="title">Primary outcomes</h5> <section id="CD010784-sec-0151"> <h6 class="title">7.1 Stone‐free rate</h6> <p>We included six studies with 335 participants (alpha‐blocker 185, placebo with/without analgesics 150) in the analysis for SFR (<a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. ">Aldaquadossi 2015</a>; <a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>; <a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] ">Erturhan 2013</a>; <a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. ">Fahmy 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). Alpha‐blockers may increase SFR (RR 1.34, 95% CI 1.16 to 1.54; low‐quality evidence). This corresponds to 199 more stone‐free patients per 1,000 (94 more to 317 more). We downgraded for study limitations and imprecision. </p> </section> <section id="CD010784-sec-0152"> <h6 class="title">7.2 Serious adverse events or complications of treatment</h6> <p>There were no serious adverse events or complications in either group.</p> </section> <section id="CD010784-sec-0153"> <h6 class="title">7.3 Secondary procedures for residual fragments</h6> <p>We included one study with 39 participants (alpha‐blocker 19, placebo with/without analgesics 20) (<a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] ">Aydogdu 2009</a>). We are uncertain about the effect of alpha‐blockers on secondary procedures (RR 0.53, 95% CI 0.15 to 1.81; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> </section> <section id="CD010784-sec-0154"> <h5 class="title">Secondary outcomes</h5> <section id="CD010784-sec-0155"> <h6 class="title">7.4 Hospital stay</h6> <p>We did not find any data related to hospital stay.</p> </section> <section id="CD010784-sec-0156"> <h6 class="title">7.5 Pain</h6> <p>We included two studies with 98 participants (alpha‐blocker 51, placebo with/without analgesics 47) (<a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. ">Elgalaly 2017</a>; <a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] ">Mokhless 2012</a>). We are uncertain about the effect of alpha‐blockers on pain episodes (MD ‐1.49, 95% CI ‐3.04 to 0.06; very low‐quality evidence). We downgraded for study limitations and very serious imprecision. </p> </section> </section> <section id="CD010784-sec-0157"> <h5 class="title">Subgroup analysis and sensitivity analysis</h5> <p>We were unable to conduct any preplanned secondary analyses due to the lack of suitable data. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010784-sec-0158" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010784-sec-0158"></div> <section id="CD010784-sec-0159"> <h3 class="title" id="CD010784-sec-0159">Summary of main results</h3> <p>We included 14 studies with a total of 978 participants in our review. The studies compared surgical and medical interventions for the treatment of upper tract stone disease in children; the data from these studies informed eight separate comparisons. The mean age of trial participants ranged from 20.3 months to 11.1 years (with an age range of 0.5 to 17 years). In the surgical group the stone size range was 5 mm to 45 mm. In the medical therapy group, stone size ranged from 2 mm to 12 mm, and in the medical and surgical intervention group the median stone size was 12 mm (10 mm to 16 mm). </p> <p><b>Shock wave lithotripsy versus dissolution therapy for intrarenal stones</b> </p> <p>We are uncertain about the effects of SWL on SFR, serious adverse events or complications of treatment, and secondary procedures for residual fragments. </p> <p><b>Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</b> </p> <p>We are uncertain about the effects of slow SWL on SFR, serious adverse events or complications of treatment, and about the effects of slow SWL on secondary procedures for residual fragments. </p> <p><b>Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones</b> </p> <p>We are uncertain about the effects of SWL on SFR, serious adverse events or complications of treatment, and secondary procedures for residual fragments. </p> <p><b>Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</b> </p> <p>SWL likely has a lower SFR. SWL appears to reduce serious adverse events but may require more secondary procedures. </p> <p><b>Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</b> </p> <p>We are uncertain about the effects of PCNL on SFR, serious adverse events, and secondary procedures. </p> <p><b>Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</b> </p> <p>PCNL likely has similar effects on SFR. We did not find any data relating to serious adverse events. We are uncertain about secondary procedures. </p> <p><b>Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones</b> </p> <p>Alpha‐blockers may increase SFR. We are uncertain about serious adverse events or complications and secondary procedures. </p> </section> <section id="CD010784-sec-0160"> <h3 class="title" id="CD010784-sec-0160">Overall completeness and applicability of evidence</h3> <p>Studies included in this review examined an important and clinically relevant topic on the treatment of upper tract urinary stones in children. The population examined is very important as there is a lack of available research evidence compared to that available for the adult population. </p> <p> <ul id="CD010784-list-0018"> <li> <p>Although all interventions assessed in this review are used to treat stone disease, the patient populations they apply to vary greatly by stone size and age. This limits any assessments across randomised comparisons. </p> </li> <li> <p>The definition of the SFR varied across the studies. In some studies the SFR was accepted if the fragments post‐treatment were less than or equal to 4 mm, whereas other studies classified SFR as no remaining fragments in the renal tract. </p> </li> <li> <p>The length of follow‐up varied between the studies and was generally limited to short‐term follow‐up of three months or less. There is a need for long‐term follow‐up data. </p> </li> <li> <p>Regarding the predefined primary and secondary outcomes in this review, half of the studies reported on all primary outcomes (SFR, complications and rate of secondary procedures). Only three studies reported pain as an outcome and five studies reported on hospital stay. </p> </li> <li> <p>We were unable to conduct any of the predefined subgroup analyses except one comparison of SWL versus ureteroscopy. Questions around differential effectiveness and safety of these interventions therefore remain unanswered. </p> </li> <li> <p>A majority of the studies are recent. This is potentially due to the increasing incidence of the nephrolithiasis in children 18 years old and younger (<a href="./references#CD010784-bbs2-0052" title="SasDJ , HulseyTC , ShatatIF , OrakJK . Incidence of kidney stones in children evaluated in the ER is increasing. The Journal of Pediatrics2010;157(1):132‐7. ">Sas 2010</a>) and increased recognition of the importance of trials in paediatric urology. </p> </li> <li> <p>The majority of comparisons assessed in this review relate to surgical innovation. In particular with regards to ureterorenoscopes and nephroscopes, there have been recent advancements in terms of miniaturisation, increased functionality (improved scope flexibility) and visualization (introduction of digital scopes; <a href="./references#CD010784-bbs2-0020" title="BorofskyMS , ShahO . Advances in ureteroscopy. Urologic Clinics of North America2013;40(1):67‐78. ">Borofsky 2013</a>). These recent advances are not captured in this review, given the paucity of trials and limiting applicability. </p> </li> <li> <p>Factors which could have significant impact on the treatment outcomes — such as contributing metabolic abnormalities, stone composition and preoperative renal function — have not been considered in most of the studies. This could have an impact on the choice of treatment modality and treatment outcomes. </p> </li> <li> <p>The applicability of the findings to high‐income countries needs consideration as the majority of the included studies were conducted in middle‐ and low‐income countries with possible variation in risk factors for stone formation, availability of certain interventions and access to paediatric care. </p> </li> <li> <p>The focus of this systematic review was direct evidence from randomised trials in paediatric patient populations. Given that the QoE was very low, it is possible that indirect evidence from adult populations or observational studies may have yielded higher quality evidence for at least some comparisons. </p> </li> </ul> </p> </section> <section id="CD010784-sec-0161"> <h3 class="title" id="CD010784-sec-0161">Quality of the evidence</h3> <p>We rated the QoE as very low for the majority of comparisons and outcomes. This means that our confidence in the effect estimate is very limited and that the true effect may be substantially different from the estimate of the effect or is likely to be substantially different from the estimate of effect. We found moderate‐quality evidence for only three comparisons but not for all three of our primary outcomes. Therefore in each case, clinicians and guidelines developers would base their decision‐making on lower quality evidence. </p> <p>Consistent issues for downgrading our assessments of the quality of the evidence were: study limitations attributable to selection bias (unclear allocation concealment), performance bias (lack of blinding of patients and personnel) and detection bias (lack of blinding of outcome assessors). We also frequently downgraded our quality assessments by two levels for imprecision. There were few studies, with small samples sizes and low events rates resulting in wide CIs that crossed assumed thresholds of clinically important differences. </p> </section> <section id="CD010784-sec-0162"> <h3 class="title" id="CD010784-sec-0162">Potential biases in the review process</h3> <p>In this review we followed the rigorous methods outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to minimise biases (<a href="./references#CD010784-bbs2-0035" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) which includes publication of an a priori protocol. Potential residual biases are nevertheless possible and may relate to the following. </p> <p> <ul id="CD010784-list-0019"> <li> <p>Publication bias: although we attempted to conduct a comprehensive search irrespective of language and publication status, it is possible that we missed non‐English studies in non‐indexed journals. </p> </li> <li> <p>Selective reporting bias and missing data: the reporting quality of most included studies was poor, prompting us to contact the authors for further information. Due to the time‐intense nature of this effort, we limited this to one attempt only. Increased efforts may have yielded a better response rate. </p> </li> </ul> </p> </section> <section id="CD010784-sec-0163"> <h3 class="title" id="CD010784-sec-0163">Agreements and disagreements with other studies or reviews</h3> <p>To date, no Cochrane review has been published on this topic. In addition, we have not identified any non‐Cochrane review that used similar rigorous methodology including a published protocol. One systematic review (<a href="./references#CD010784-bbs2-0021" title="BragaLH , PembertonJ , DemariaJ , LorenzoAJ . Methodological concerns and quality appraisal of contemporary systematic reviews and meta‐analyses in pediatric urology. Journal of Urology2011;186(1):266‐71. ">Braga 2011</a>) has previously described the limitations and challenges of systematic reviews in paediatric urology. We identified one study on medical expulsive therapy that used GRADE to assess methodological quality (<a href="./references#CD010784-bbs2-0029" title="GlinaFP , CastroPM , MonteiroGG , DelGuerraGC , GlinaS , MazzuranaM , et al. The use of alpha‐1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta‐analysis. International Brazilian Journal of Urology2015;41(6):1049‐57. ">Glina 2015</a>; see below). </p> <p>We identified two systematic reviews (<a href="./references#CD010784-bbs2-0036" title="IshiiH , GriffinS , SomaniBK . Flexible ureteroscopy and lasertripsy (FURSL) for paediatric renal calculi: results from a systematic review. Journal of Pediatric Urology2014;10(6):1020‐5. ">Ishii 2014</a>; <a href="./references#CD010784-bbs2-0037" title="IshiiH , GriffinS , SomaniBK . Ureteroscopy for stone disease in the paediatric population: a systematic review. BJU International2015;115(6):867‐73. ">Ishii 2015</a>) assessing ureteroscopy and three systematic reviews assessing medical expulsive therapy (<a href="./references#CD010784-bbs2-0029" title="GlinaFP , CastroPM , MonteiroGG , DelGuerraGC , GlinaS , MazzuranaM , et al. The use of alpha‐1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta‐analysis. International Brazilian Journal of Urology2015;41(6):1049‐57. ">Glina 2015</a>; <a href="./references#CD010784-bbs2-0059" title="TianD , LiN , HuangW , ZongH , ZhangY . The efficacy and safety of adrenergic alpha‐antagonists in treatment of distal ureteral stones in pediatric patients: A systematic review and meta‐analysis. Journal of Pediatric Surgery2017;52(2):360‐5. ">Tian 2017</a>; <a href="./references#CD010784-bbs2-0061" title="VelazquezN , ZapataD , WangHH , WienerJS , LipkinME , RouthJC . Medical expulsive therapy for pediatric urolithiasis: Systematic review and meta‐analysis. Journal of Pediatric Urology2015;11(6):321‐7. ">Velazquez 2015</a>). </p> <p><a href="./references#CD010784-bbs2-0029" title="GlinaFP , CastroPM , MonteiroGG , DelGuerraGC , GlinaS , MazzuranaM , et al. The use of alpha‐1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta‐analysis. International Brazilian Journal of Urology2015;41(6):1049‐57. ">Glina 2015</a> analysed alpha‐1 adrenergic blockers as medical expulsive treatment in children with distal ureterolithiasis. They included three RCTs in the meta‐analysis, looking at expulsion rates and pain episodes. They concluded that use of an alpha‐1 adrenergic blocker is related to a greater incidence of expulsion of ureteral calculi and fewer episodes of pain when compared to ibuprofen. </p> <p><a href="./references#CD010784-bbs2-0037" title="IshiiH , GriffinS , SomaniBK . Ureteroscopy for stone disease in the paediatric population: a systematic review. BJU International2015;115(6):867‐73. ">Ishii 2015</a> analysed 14 studies and included non‐RCTs in the meta‐analysis. They looked at ureteroscopic failure rates and complications. They concluded that the use of ureteroscopy as the first‐line surgical management is a safe and highly effective intervention, with a small proportion of the study population having minor complications. </p> <p><a href="./references#CD010784-bbs2-0036" title="IshiiH , GriffinS , SomaniBK . Flexible ureteroscopy and lasertripsy (FURSL) for paediatric renal calculi: results from a systematic review. Journal of Pediatric Urology2014;10(6):1020‐5. ">Ishii 2014</a> identified and analysed six studies looking at SFR and complication rates in flexible ureteroscopy and laser lithotripsy. All these studies were retrospective studies. They have concluded that flexible ureteroscopy and laser lithotripsy is an effective and safe procedure in high‐volume centres. </p> <p><a href="./references#CD010784-bbs2-0059" title="TianD , LiN , HuangW , ZongH , ZhangY . The efficacy and safety of adrenergic alpha‐antagonists in treatment of distal ureteral stones in pediatric patients: A systematic review and meta‐analysis. Journal of Pediatric Surgery2017;52(2):360‐5. ">Tian 2017</a> analysed effects of alpha‐blockers (tamsulosin and doxazosin) on stone expulsion rate, stone expulsion time, and treatment‐emergent adverse events. Four RCTs and one cohort study were included in the meta‐analysis. The results of the review regarding the stone expulsion rate suggested that adrenergic alpha‐antagonists significantly improved the stone expulsion rate compared to the placebo. There was no significant difference between the adrenergic alpha‐antagonists and the placebo groups in terms of adverse events. </p> <p><a href="./references#CD010784-bbs2-0061" title="VelazquezN , ZapataD , WangHH , WienerJS , LipkinME , RouthJC . Medical expulsive therapy for pediatric urolithiasis: Systematic review and meta‐analysis. Journal of Pediatric Urology2015;11(6):321‐7. ">Velazquez 2015</a> analysed effects of alpha‐blockers on stone expulsion rate and adverse events. They identified and included in the meta‐analysis three RCTs and two retrospective cohort studies. The conclusion from the meta‐analysis is that medical expulsion therapy results in increased ureteral stone passage and a low rate of adverse events. </p> <p><a href="./references#CD010784-bbs2-0017" title="SaadKSM , YoussifME , HamdyS , FahmyA , ElDin HannoA , El‐NahasAR . Percutaneous nephrolithotomy vs retrograde intrarenal surgery for large renal stones in pediatric patients: A randomized controlled trial. Source Journal of UrologyDec 2015;194(6):p. 1716‐20. ">Saad 2015</a> compared PCNL to ureterorenoscopy in 38 randomised patients. While they reported no difference in SFR, serious adverse events or complications of treatment and secondary procedures, they reported 43 renal units instead of randomised participants which causes unit of analysis error. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010784-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram." data-id="CD010784-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD010784-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD010784-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Shock wave lithotripsy versus dissolution therapy for renal stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Shock wave lithotripsy versus dissolution therapy for renal stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Shock wave lithotripsy versus dissolution therapy for renal stones, Outcome 2 Serious adverse events or complications." data-id="CD010784-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Shock wave lithotripsy versus dissolution therapy for renal stones, Outcome 2 Serious adverse events or complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Shock wave lithotripsy versus dissolution therapy for renal stones, Outcome 3 Secondary procedures." data-id="CD010784-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Shock wave lithotripsy versus dissolution therapy for renal stones, Outcome 3 Secondary procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones, Outcome 2 Serious adverse events or complications." data-id="CD010784-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones, Outcome 2 Serious adverse events or complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones, Outcome 3 Secondary procedures." data-id="CD010784-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones, Outcome 3 Secondary procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 2 Serious adverse events or complications of treatment." data-id="CD010784-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 2 Serious adverse events or complications of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 3 Second procedures." data-id="CD010784-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 3 Second procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 4 Hospital stay (hours)." data-id="CD010784-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones, Outcome 4 Hospital stay (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 2 Serious adverse events or complications of treatment." data-id="CD010784-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 2 Serious adverse events or complications of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 3 Secondary procedures." data-id="CD010784-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 3 Secondary procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 4 Hospital stay (days)." data-id="CD010784-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones, Outcome 4 Hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 2 Serious adverse events or complications of treatments." data-id="CD010784-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 2 Serious adverse events or complications of treatments. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 3 Secondary procedures." data-id="CD010784-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 3 Secondary procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 4 Hospital stay (hours)." data-id="CD010784-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 4 Hospital stay (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 5 Pain (dose of morphine)." data-id="CD010784-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones, Outcome 5 Pain (dose of morphine). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones, Outcome 2 Secondary procedures." data-id="CD010784-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones, Outcome 2 Secondary procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones, Outcome 3 Hospital stay (days)." data-id="CD010784-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones, Outcome 3 Hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 1 Stone‐free rate." data-id="CD010784-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 1 Stone‐free rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 2 Serious adverse events or complications of treatments." data-id="CD010784-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 2 Serious adverse events or complications of treatments. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 3 Secondary procedures." data-id="CD010784-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 3 Secondary procedures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010784-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/urn:x-wiley:14651858:media:CD010784:CD010784-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_t/tCD010784-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 4 Pain (episode)." data-id="CD010784-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones, Outcome 4 Pain (episode). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/media/CDSR/CD010784/image_n/nCD010784-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Shock wave lithotripsy versus dissolution therapy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with uncomplicated radiolucent renal stone </p> <p><b>Intervention:</b> SWL (Lithotripter S; total count of 2,000 per session at 12 to 14 kV power and a frequency of 60 to 70 per minute) under general anaesthesia </p> <p><b>Control:</b> oral potassium sodium hydrogen citrate at a dose of 1 mEq/kg per day in 2 or 3 divided doses after meals </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Dissolution therapy for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>87<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/> (0.90 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>729 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 more per 1,000<br/> (73 fewer to 299 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>87<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.23<br/> (0.08 to 19.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 more per 1,000<br/> (19 fewer to 376 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures for residual fragments<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>87<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.29 to 1.50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>271 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92 fewer per 1,000<br/> (192 fewer to 135 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear or high risk of bias in almost all domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Shock wave lithotripsy versus dissolution therapy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with solitary radiopaque renal stone </p> <p><b>Intervention:</b> SWL (Dornier Lithotripter S; total count of 2,500 per session at 14 to 24 kV power) at 80 shock waves per minute </p> <p><b>Control:</b> SWL (Dornier Lithotripter S; total count of 2,500 per session at 14 to 24 kV power) at 120 shock waves per minute </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with rapid SWL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with slow SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 1 month </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.25<br/> (1.16 to 4.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>267 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333 more per 1,000<br/> (43 more to 896 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 1 month </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures</p> <p>Follow‐up: not reported (minimum 1 month)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.38<br/> (0.11 to 1.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>267 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165 fewer per 1,000<br/> (237 fewer to 75 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear risk of bias in half or more domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinical meaningful threshold. </p> <p><sup>3</sup> Downgraded by two levels for imprecision: very rare event in either group. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with renal or distal ureteric stones </p> <p><b>Intervention:</b> SWL (Compact Delta II with 1,250 to 2,400 (mean 1,530) shockwave and power ranged from 11 to 13 kV, EDAP‐Sonolith 4000 with 2500 shock waves (1900–3500) and 450 KJ (330–694)) </p> <p><b>Control:</b> lithotripsy with holmium laser and/or pneumatic lithotriptor </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Ureteroscopy with Holmium laser or Pneumatic lithotripsy for distal ureteric stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: range 2 weeks to 8 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>153<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.62<br/> (0.43 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>859 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>326 fewer per 1,000<br/> (490 fewer to 103 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: range 2 weeks to 8 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>153<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.56<br/> (0.12 to 2.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 fewer per 1,000<br/> (45 fewer to 81 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Second procedures<br/> Follow‐up: range 2 weeks to 8 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>131<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.47<br/> (1.32 to 9.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>149 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>369 more per 1,000<br/> (48 more to 1,216 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: hours </p> <p>Follow‐up: range 2 weeks to 3 months<sup>5</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>122<br/> (2 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay ranged from 4 to 36 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 10.71 hours lower<br/> (34.09 lower to 12.67 higher) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear of high risk of bias in half or more domains among the included studies. </p> <p><sup>2</sup> Downgraded by one level for indirectness: discrepancies in inclusion criterion (<a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a> included only participants with a solitary kidney) and baseline stone size among included studies. In addition, stones were in different locations (renal and distal ureter) among included studies. </p> <p><sup>3</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> <p><sup>4</sup> Downgraded by one level for imprecision: confidence interval crosses clinically meaningful threshold. </p> <p><sup>5</sup><a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. ">Gamal 2017</a> did not report the follow‐up period. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and distal ureteric stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> age &lt; 15 years and single radio‐opaque lower calyceal calculus 1‐2cm </p> <p><b>Intervention:</b> SWL as an outpatient procedure (Dornier Alpha Compact system; maximum 2,500 per session and a frequency of 90 per minute) </p> <p><b>Control:</b> mini‐PCNL under general anaesthesia </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Mini‐PCNL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with SWL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.88<br/> (0.80 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>943 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113 fewer per 1,000<br/> (189 fewer to 28 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.13</p> <p>(0.02 to 0.98)</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66 fewer per 1,000</p> <p>(74 fewer to 2 fewer)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.50<br/> (1.01 to 6.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 more per 1,000<br/> (1 more to 294 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: days<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay was 3.7 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.4 days lower<br/> (5.43 lower to 1.37 lower) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>PCNL:</b> percutaneous nephrolithotomy; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SWL:</b> shock wave lithotripsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear of high risk of bias in half or more domains. </p> <p><sup>2</sup> Downgraded by one level for imprecision: confidence interval crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> age &lt; 14 years, presence of renal stone larger than 2.5 cm or renal stone with lesser diameter, and extracorporeal shockwave lithotripsy failure </p> <p><b>Intervention:</b> PCNL under general anaesthesia </p> <p><b>Control:</b> tubeless PCNL under general anaesthesia </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Tubeless PCNL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with PCNL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.16<br/> (0.88 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>846 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135 more per 1,000<br/> (102 fewer to 448 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatments<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.42<br/> (0.02 to 9.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 fewer per 1,000</p> <p>(75 fewer to 648 more)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.42<br/> (0.02 to 9.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 fewer per 1,000<br/> (75 fewer to 648 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: hours<br/> Follow‐up: mean 1 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay was 39.5 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 19.2 hours more<br/> (10.2 more to 28.08 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>PCNL:</b> percutaneous nephrolithotomy; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear or high risk of bias in half or more domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> <p><sup>3</sup> Downgraded by one level for imprecision: confidence interval crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> preschool children under 3 years with renal calculi </p> <p><b>Intervention:</b> PCNL under general anaesthesia </p> <p><b>Control:</b> mini‐PCNL under general anaesthesia </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Mini‐PCNL for renal stones</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with PCNL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.93 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>943 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 more per 1,000<br/> (66 fewer to 132 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events or complications of treatment — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures<br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay<br/> assessed with: days<br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean hospital stay was 4.6 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.14 days more<br/> (2.78 more to 3.5 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>PCNL:</b> percutaneous nephrolithotomy; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear risk of bias in almost all domains. </p> <p><sup>2</sup> Downgraded by two levels for imprecision: very rare event in either group. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010784-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Alpha‐blockers versus placebo with/without analgesics</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participants:</b> children with radiopaque lower ureteral stones </p> <p><b>Intervention:</b> alpha blockers (doxazosin, tamsulosin, or silodosin) </p> <p><b>Control:</b> placebo with/without analgesics </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo with/without analgesics</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with alpha‐blockers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Stone‐free rate<br/> Follow‐up: range 3 weeks to 4 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>335<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.34<br/> (1.16 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>587 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199 more per 1,000<br/> (94 more to 317 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events or complications of treatment<br/> Follow‐up: mean 4 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>63<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary procedures for residual fragments<br/> Follow‐up: mean 3 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/> (0.15 to 1.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141 fewer per 1,000<br/> (255 fewer to 243 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital stay — not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: unclear or high risk of bias in one or more domains. </p> <p><sup>2</sup> Downgraded by one levels for imprecision: confidence interval is crosses clinically meaningful threshold. </p> <p><sup>3</sup> Downgraded by two levels for imprecision: very rare event in either group. </p> <p><sup>4</sup> Downgraded by two levels for imprecision: confidence interval is very wide and crosses clinically meaningful threshold. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Alpha‐blockers versus placebo with/without analgesics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010784-tbl-0008"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of the interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) appropriate as applied in a clinical practice setting<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparator(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparator(s) appropriate as applied in a clinical practice setting<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] "><b>Aghamir 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Puncture was performed in the prone position by 18‐gauge nephrostomy needle, under fluoroscopic guidance the tract was dilated by coaxial serial metallic dilators, an Amplatz sheath up to 28 F, and up to 26 F Storz nephroscope was used, the stone fragmentation was performed with a pneumatic lithotripter (EMS Swiss lithoclast) and residual stones were extracted with a grasper, both ureteral stent and the working sheath were removed at the end of procedure without placing any nephrostomy tube. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Puncture was performed in the prone position by 18‐gauge nephrostomy needle, under fluoroscopic guidance the tract was dilated by coaxial serial metallic dilators, an Amplatz sheath up to 28 F, and up to 26 F Storz nephroscope was used, the stone fragmentation was performed with a pneumatic lithotripter (EMS Swiss lithoclast) and residual stones were extracted with a grasper, ureteral stent was remained and a nephrostomy tube was placed through the working sheath for 24–48 hours. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. "><b>Aldaquadossi 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: alpha‐1 blocker (tamsulosin) therapy in addition to ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsulosin 0.4 mg for patients aged &gt; 5 years and 0.2 mg for younger children and Ibuprofen 4–10 mg/kg orally every 6–8 h as needed. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Ibuprofen only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen 4–10 mg/kg orally every 6–8 h as needed.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] "><b>Aydogdu 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen (20 mg/kg daily divided into 2 equal doses).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Doxazosin and ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen (20 mg/kg daily divided into 2 equal doses) and doxazosin dose was approximately 0.03 mg/kg once daily. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] "><b>Basiri 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Transureteral lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients were placed in the lithotomy position and a 6 Fr or 8.5 Fr semirigid ureteroscope was passed into the ureter using a safety guidewire, the ureteral calculus fragmentation was performed with holmium laser or pneumatic lithotripsy. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shock wave was delivered by under‐table Compact Delta II electromagnetic sources, with patients in the prone position under ultrasound or fluoroscopic guidance, impulse rate per treatment varied from 1,250 to 2,400 (mean 1,530) and power ranged from 11 to 13 kV. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] "><b>De Domenicis 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ureteroscopy plus intracorporeal lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For ureteroscopy the 7.5 F ureteroscope with a 5 F operative channel was used (Storz, Germany) and the Lithoclast® ballistic lithotripter (1.9 F tapered semiflexible probe) or holmium‐YAG laser (400 mm fibres) was used for disintegrating the stones in the distal ureter, patient in the dorsal lithotomy position, paediatric cystoscope was used to place a 4.8 F open‐ended catheter to the level of the intramural ureter, and a low‐pressure retrograde ureteropyelogram was done, a 0.9 mm PTFE guidewire was used as a safety wire, the second/ working guidewire was used for insertion of the ureteroscope, ureteric dilators (6–9 F) were used in two cases, the semiflexible probe of the Lithoclast or laser fibre was used for the lithotripsy. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Extracorporeal shock wave<br/> lithotripsy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EDAP‐Sonolith 4000 + lithotripter was used in prone prone position, ≈2500 shock waves (1900–3500) were delivered, usually at 450 KJ (330–694), ureteric open‐ended catheter was left in place and removed in the next 24–72 h. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. "><b>Elderwy 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Dissolution therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral potassium sodium hydrogen citrate was administered at a dose of 1 mEq/kg per day in 2 or 3 divided doses after meals for 1 to 3 months. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lithotripter S was used, a total count of 2,000 shock waves per session at 12 to 14 kV power and a frequency of 60 to 70 per minute. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. "><b>Elgalaly 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silodosin 4 mg at bedtime. Ibuprofen<br/> (20 mg/kg/day) was divided into two doses for pain episodes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo at bedtime. Ibuprofen (20 mg/kg/day) was divided into two doses for pain episodes.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] "><b>Erturhan 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen 20 mg/kg/d divided into 2 equal doses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: alpha‐1 blocker (doxazosin) therapy in addition to ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen 20 mg/kg/d divided into 2 equal doses and 0.03 mg/kg/d doxazosin once daily, before bed. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. "><b>Fahmy 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 mg silodosin daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Tamsuosin or placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsulosin group 0.4 mg tamsulosin daily, placebo group were not given any medications.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. "><b>Gamal 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Flexible ureteroscopy plus lasertripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A 7.5 Fr flexible ureteroscope (FURS) was introduced into the ureter over a hydrophilic guidewire under visual and fluoroscopic guidance without access sheath. Complete stone dusting using 200 mm laser fiber (0.2‐1.0 joules power and15‐30 Hz frequency) was done in all cases ending with a 5 Fr JJ stent insertion. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. "><b>Kumar 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Mini percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5F open‐ended ureteral catheter was placed in the renal pelvis cystoscopically, anatomy of the pelvicaliceal system was assessed by infusing contrast media via the ureteral catheter, selected calix was punctured under fluoroscopy guidance by an 18‐gauge needle using the ‘‘bulls eye technique,’’ the tract was dilated to 18F, 15F miniature nephroscope (Richard Wolf, Vernon Hills, IL) was used with pneumatic intracorporeal lithotripsy, stone fragmentation and clearance were confirmed by direct vision and under fluoroscopy, 12F nephrostomy tube, kept in situ for drainage, was removed once urine was clear. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 minutes before the procedure 5 gm of a eutectic mixture of lidocaine and prilocaine was applied on approximately 30 cm2 area of skin corresponding to the site of entry of shockwaves electromagnetic lithotripter (Dornier Alpha Compact system, Wessling, Germany), the shockwave delivery rate was 90 pulses per minute, the maximum number of shockwaves was 2500 per session. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] "><b>Mokhless 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tamsulosin and standard analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsulosin 0.4 mg for children older than 4 years and 0.2 mg for younger children at bed time in addition to standard analgesia (ibuprofen). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo and standard analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard analgesia (ibuprofen) and placebo.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. "><b>Salem 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Slow delivery rate shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Using the Dornier Lithotripter S (Dornier Medical Systems, Kennesaw, Georgia) with the 220 electromagnetic shock wave emitter, fluoroscopy was used for stone localisation, energy was increased gradually from 14 to 20 kV, in children younger than 4 years the energy was increased to 18 kV, 80 shock waves per minute were used, maximum number of shock waves delivered was 2,500. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Rapid delivery rate shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Using the Dornier Lithotripter S (Dornier Medical Systems, Kennesaw, Georgia) with the 220 electromagnetic shock wave emitter, fluoroscopy was used for stone localisation, energy was increased gradually from 14 to 20 kV, in children younger than 4 years the energy was increased to 18 kV, 120 shock waves per minute were used, maximum number of shock waves delivered was 2,500. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. "><b>Song 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless mini‐percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>F4 ureteral catheter inserted into the affected renal pelvis through the paediatric cystoscope, Foley catheter was placed and fixed to the ureteral catheter with surgical threads, sterile saline was flushed into the kidney through the ureteral catheter to create an artificial hydronephrosis, 18G biopsy needle was inserted to the targeted renal pelvis, ureteral catheter was expanded by fascia dilator to F14 or F16 while the sheath was left in place, paediatric nephroscope or ureteroscope was inserted and stones fragmented by holmium laser, fragments were picked or washed out by lavage fluid, residual stones were removed completely or the second nephrostomy access tract for lithotripsy was selected for<br/> complete clearance. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>F4 ureteral catheter inserted into the affected renal pelvis through the paediatric cystoscope, Foley catheter was placed and fixed to the ureteral catheter with surgical threads, sterile saline was flushed into the kidney through the ureteral catheter to create an artificial hydronephrosis, 18G biopsy needle was inserted to the targeted renal pelvis, ureteral catheter was expanded by fascia dilator to F14 or F16 while the sheath was left in place, paediatric nephroscope or ureteroscope was inserted and stones fragmented by holmium laser, fragments were picked or washed out by lavage fluid, residual stones were removed completely or the second nephrostomy access tract for lithotripsy was selected for complete clearance, the nephrostomy tube was removed 24 hours later. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>‐ denotes not reported</p> <p><sup>a</sup>The term 'clinical practice setting' refers to the specification of the intervention/comparator as used in the course of a standard medical treatment (such as dose, dose escalation, dosing scheme, provision for contraindications and other important features). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><b>C</b> : comparator; <b>I</b> : intervention; <b>IL</b> : Illinois;<b>h</b> : hours <b>PTFE</b> : polytetrafluoroethylen; <b>YAG</b>: yattrium aluminium garnet. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of the interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010784-tbl-0009"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention (duration of follow‐up)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0001" title="AghamirSM , SalavatiA , AlooshM , FarahmandH , MeysamieA , PourmandG . Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. Journal of Endourology2012;26(6):621‐4. [MEDLINE: 22192104] "><b>Aghamir 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 24‐48 hours after surgery, one week and one month after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 14 years old, renal stone &gt; 2.5 cm or renal stone with lesser diameter, and extracorporeal shockwave lithotripsy failure </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2010‐2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0002" title="AldaqadossiHA , ShakerH , SaifelnasrM , GaberM . Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab Journal of Urology2015;13:107‐111. "><b>Aldaquadossi 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: alpha‐1 blocker (tamsulosin) therapy in addition to ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: weekly for 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Group 1: 33 children ‐ mean age 7.7 years; group 2: 34 children ‐ mean age 7.25 years, distal ureteric stone of &lt; 1 cm, and below the common iliac vessels </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2010‐2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Ibuprofen only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0003" title="AydogduO , BurguB , GucukA , SuerE , SoygurT . Effectiveness of doxazosin in treatment of distal ureteral stones in children. Journal of Urology2009;182(6):2880‐4. [MEDLINE: 19846149] "><b>Aydogdu 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 19 days (mean)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2‐14 years old, radio‐opaque lower ureteral stone 2‐10 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2005‐2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Doxazosin and ibuprofen</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0004" title="BasiriA , ZareS , TabibiA , SharifiaghdasF , AminsharifiA , Mousavi‐BaharSH , et al. A multicenter, randomized, controlled trial of transureteral and shock wave lithotripsy—which is the best minimally invasive modality to treat distal ureteral calculi in children?. Journal of Urology2010;184(3):1106‐9. [MEDLINE: 20650490] "><b>Basiri 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Transureteral lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 2 weeks postoperatively with ultrasound, another at 3 months with excretory urography (more frequent if persistent stone present) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1‐13 years old, distal ureteral calculi 15‐56 mm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2007‐2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shock wave lithotripsy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0005" title="DeDominicisM , MatarazzoE , CapozzaN , ColluraG , CaioneP . Retrograde ureteroscopy for distal ureteric stone removal in children. BJU International2005;95(7):1049‐52. [MEDLINE: 15839930] "><b>De Domenicis 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ureteroscopy plus intracorporeal lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 6‐8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2‐17 years old, radio‐opaque calculi in distal ureter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1 year (time range not specified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Extracorporeal shock wave<br/> lithotripsy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0006" title="ElderwyA , KurkarA , HusseinA‐M , AbozeidH , HammoddaM , IbraheimA‐F . Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. The Journal of Urology2014;191(5):1491. "><b>Elderwy 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Dissolution therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: every 3‐4 weeks and every 3‐4 months thereafter</p> <p>length of treatment: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.5‐13 years old, renal calculi 7‐24 mm &lt; 500 HU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2010‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard shock wave lithotripsy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0007" title="ElgalalyH , EliwaA , SeleemM , SalemE , OmranM , ShelloH , et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo‐controlled study. Arab Journal of Urology2017;15:194‐8. "><b>Elgalaly 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: history, physical examination, urine analysis, KUB, ultrasonography at 2 and 4 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 18 years old, single unilateral radiopaque DUS, and largest stone diameter of ≤ 10 mm </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2014‐2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hopsital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0008" title="ErturhanS , BayrakO , SaricaK , SeckinerI , BaturuM , SenH . Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology2013;81(3):640‐3. [MEDLINE: 23343614] "><b>Erturhan 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Ibuprofen only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: for 3 weeks with weekly examinations</p> <p>length of treatment: 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3‐15 years old, lower ureteral stones (group 1: 4.45 ± 1.5 mm, group 2: 4.58 ± 1.7 mm) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>not disclosed in the study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hopsital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: alpha‐1 blocker (doxazosin) therapy in addition to ibuprofen</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0009" title="FahmyA , RhasadH , KamalA , ElsawyM . Silodosin for medical expulsive therapy in children with distal ureteran stone: a prospective randomized, placebo‐controlled, single blind study. The Journal of Urology. 2017; Vol. 197:1217. "><b>Fahmy 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Silodosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: stone free rate assessed after 4 weeks. Further details of follow up not supplied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 18 years old, unilateral, single, radio‐opaque distal ureteral stones &lt; 10 mm in size </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hopsital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Tamsuosin or placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0010" title="GamalW , MmdouhA , Sogah . FURS vs shockwave lithotripsy for treatment of (1‐2) cm renal stones in children with a solitary kidney: A prospective randomized study. The Journal of Urology. 2017; Vol. 197:578. "><b>Gamal 2017</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Flexible ureteroscopy plus lasertripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: stone free rate assessed after 1 month. Further details of follow up not supplied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 15 years old, with a renal stones (1‐2) cm in a solitary kidney</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2011‐2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0011" title="KumarA , KumarN , VasudevaP , KumarR , JhaSK , SinghH . A single center experience comparing miniperc and shockwave lithotripsy for treatment of radiopaque 1‐2 cm lower caliceal renal calculi in children: a prospective randomized study. Journal of Endourology / Endourological Society2015;29(7):805. "><b>Kumar 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Mini percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 15 years old, single lower caliceal stone 1‐2 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2012‐2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Shockwave<br/> lithotripsy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0012" title="MokhlessI , YoussifM , ZahranA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study [abstract no: S2‐2]. 22nd Annual Congress of the European Society for Pediatric Urology (ESPU); 2011 Apr 27‐30; Copenhagen, Denmark. 2011. MokhlessI , ZahranAR , YoussifM , FahmyA . Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. Journal of Pediatric Urology2012;8(5):544‐8. [MEDLINE: 22099477] "><b>Mokhless 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tamsulosin and standard analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: close for 4 weeks</p> <p>Length of treatment: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2‐15 years old, distal ureteric calculi &lt; 12 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2007‐2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Placebo and standard analgesia</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0013" title="SalemHK , FathyH , ElfayoumyH , AlyH , GhoniumA , MohsenA , et al. Slow versus rapid delivery rate shock wave lithotripsy for pediatric renal urolithiasis: a prospective randomized study. The Journal of Urology2014;191(5):1370. "><b>Salem 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Slow delivery rate shock wave lithotripsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 2 and 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3‐14 years old, renal calculi 10‐20 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2011‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Rapid delivery rate shock wave lithotripsy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010784-bbs2-0014" title="SongG , GuoX , NiuG , WangY . Advantages of tubeless mini‐percutaneous nephrolithotomy in the treatment of preschool children under 3 years old. Journal of Pediatric Surgery2015;50(4):655. "><b>Song 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: Tubeless mini‐percutaneous nephrolithotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Follow‐up: 1, 3, 6, 12 months postoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7‐36 months old, renal stones with cumulative diameter &lt; 4.5 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2009‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C: Standard percutaneous nephrolithotomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>If a field is left empty, the study did not contain the required information.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><b>KUB</b>: kidney, ureter, and bladder. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/full#CD010784-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Shock wave lithotripsy versus dissolution therapy for renal stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.90, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events or complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.08, 19.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Secondary procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.29, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Shock wave lithotripsy versus dissolution therapy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.25 [1.16, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events or complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Secondary procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.11, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Slow shock wave lithotripsy versus rapid shock wave lithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.43, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Renal stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.25, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Distal ureteral stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.39, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events or complications of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.12, 2.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Renal stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.02, 7.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Distal ureteral stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Second procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.47 [1.32, 9.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Renal stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.86, 41.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Distal ureteral stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.46 [0.82, 14.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hospital stay (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.71 [‐34.09, 12.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Renal stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐1.07, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Distal ureteral stone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐24.0 [‐39.45, ‐8.55]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Shock wave lithotripsy versus ureteroscopy with holmium laser or pneumatic lithotripsy for renal and ureteric stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.80, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events or complications of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Secondary procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [1.01, 6.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐5.43, ‐1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Shock wave lithotripsy versus mini‐percutaneous nephrolithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.88, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events or complications of treatments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.02, 9.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Secondary procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.02, 9.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hospital stay (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.16 [10.24, 28.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain (dose of morphine) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.05, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless percutaneous nephrolithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.93, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Secondary procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.14 [2.78, 3.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Percutaneous nephrolithotripsy versus tubeless mini‐percutaneous nephrolithotripsy for renal stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010784-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Stone‐free rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [1.16, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events or complications of treatments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Secondary procedures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.15, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain (episode) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.49 [‐3.04, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Alpha‐blockers versus placebo with/without analgesics for distal ureteric stones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010784.pub3/references#CD010784-tbl-0016">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010784.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010784-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010784-note-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010784-note-0017">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ko#CD010784-note-0016">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010784-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD010784-note-0003">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD010784-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010784-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010784\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010784\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010784\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010784\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010784\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XHP2gG4h&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010784.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010784.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010784.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010784.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010784.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719032133"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010784.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719032137"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010784.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dded75c791be4',t:'MTc0MDcxOTAzMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 